<![CDATA[JSCAI BEATS]]>https://www.jscai.org/Riverside.fm (https://riverside.com)Mon, 09 Nov 2026 14:33:51 GMTWed, 10 Dec 2025 18:56:52 GMT60The Journal of the Society for Cardiovascular Angiography &amp; InterventionsInterventional Cardiology experts explore the latest breakthroughs, insights, and exclusive interviews from The Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI), SCAI's official journal. Stay connected with your on-the-go journal resource for the latest cutting-edge developments, innovations, and research.episodicThe Journal of the Society for Cardiovascular Angiography &amp; InterventionsJSCAI@scai.orgno<![CDATA[Contemporary Chronic Limb-Threatening Ischemia Care in the United States: Part 1 & 2]]>At VIVA Conference 2025, an in-person panel featuring Eric Secemsky, Ehrin Armstrong, Sahil Parikh, Venita Chandra, and Saher Sabri highlighted the major themes from the two-part series, Contemporary Chronic Limb-Threatening Ischemia Care in the United States, published in JSCAI. Based on the work of the Vascular InterVentional Advances (VIVA) Foundation—which convened a multispecialty Vascular Leaders Forum to openly address challenges in CLTI care and optimize the design of medical device trials—the papers draw on this collaborative discussion. The series emphasizes rising amputation trends, gaps in access, and the need for stronger cross-specialty integration. The experts highlighted the urgent need for multispecialty collaboration in CLTI care (Part 1) and addressed critical gaps in comparative evidence for revascularization strategies (Part 2).Part 1: https://www.jscai.org/article/S2772-9303(25)01459-0/fulltext Part 2: https://www.jscai.org/article/S2772-9303(25)01380-8/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Contemporary-Chronic-Limb-Threatening-Ischemia-Care-in-the-United-States-Part-1--2-e3bntcbca06cce8-5667-4a76-bfca-2645701729c5Mon, 01 Dec 2025 19:09:08 GMT<p>At VIVA Conference 2025, an in-person panel featuring Eric Secemsky, Ehrin Armstrong, Sahil Parikh, Venita Chandra, and Saher Sabri highlighted the major themes from the two-part series, Contemporary Chronic Limb-Threatening Ischemia Care in the United States, published in JSCAI. Based on the work of the Vascular InterVentional Advances (VIVA) Foundation—which convened a multispecialty Vascular Leaders Forum to openly address challenges in CLTI care and optimize the design of medical device trials—the papers draw on this collaborative discussion. The series emphasizes rising amputation trends, gaps in access, and the need for stronger cross-specialty integration. The experts highlighted the urgent need for multispecialty collaboration in CLTI care (Part 1) and addressed critical gaps in comparative evidence for revascularization strategies (Part 2).Part 1: https://www.jscai.org/article/S2772-9303(25)01459-0/fulltext Part 2: https://www.jscai.org/article/S2772-9303(25)01380-8/fulltext</p> no00:17:52Contemporary Chronic Limb-Threatening Ischemia Care in the United States: Part 1 & 2full<![CDATA[Economic Barriers to IC Care for Adults and Children with CHD and Potential Policy Solutions: A SCAI Policy Statement]]>SCAI experts Drs. Lyndon Box, Frank Ing, Dennis Kim, and Holly Bauser-Heaton discuss a new original research article outlining the economic challenges impacting access to interventional cardiology care for adults and children with congenital heart disease. They discuss SCAI’s policy recommendations and explore practical solutions to improve equity and affordability. Watch to learn about the challenges patients face, the impact on access to care, and the policy recommendations aimed at driving meaningful change. Read the full JSCAI article here: https://www.jscai.org/article/S2772-9303(25)01315-8/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Economic-Barriers-to-IC-Care-for-Adults-and-Children-with-CHD-and-Potential-Policy-Solutions-A-SCAI-Policy-Statement-e3bgl3d8074dc00-49f9-47a2-93d7-622c1563a2f6Wed, 26 Nov 2025 15:59:39 GMT<p>SCAI experts Drs. Lyndon Box, Frank Ing, Dennis Kim, and Holly Bauser-Heaton discuss a new original research article outlining the economic challenges impacting access to interventional cardiology care for adults and children with congenital heart disease. They discuss SCAI’s policy recommendations and explore practical solutions to improve equity and affordability. Watch to learn about the challenges patients face, the impact on access to care, and the policy recommendations aimed at driving meaningful change. Read the full JSCAI article here: <a href="https://www.jscai.org/article/S2772-9303(25)01315-8/fulltext" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/article/S2772-9303(25)01315-8/fulltext</a></p> no00:25:56Economic Barriers to IC Care for Adults and Children with CHD and Potential Policy Solutions: A SCAI Policy Statementfull<![CDATA[Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systems]]>Drs. Dean Kereiakes, Robert Riley, Nadia Sutton, and Amit Vora discuss the findings from the study “Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systems,” which evaluates performance and safety improvements in modern shielding technologies. Learn how these innovations aim to reduce radiation exposure and enhance protection in clinical environments.Read the full article here: https://www.jscai.org/article/S2772-9303(25)01228-1/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Comparative-Effectiveness-of-2-Next-Generation-Scatter-Radiation-Shielding-Systems-e3bf3ff76701cb5-9446-44e7-84ca-b3b8c6abef91Tue, 25 Nov 2025 16:31:02 GMT<p>Drs. Dean Kereiakes, Robert Riley, Nadia Sutton, and Amit Vora discuss the findings from the study “Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systems,” which evaluates performance and safety improvements in modern shielding technologies. Learn how these innovations aim to reduce radiation exposure and enhance protection in clinical environments.Read the full article here: https://www.jscai.org/article/S2772-9303(25)01228-1/fulltext</p> no00:34:21Comparative Effectiveness of 2 Next-Generation Scatter Radiation Shielding Systemsfull<![CDATA[The Ringer Study: Clinical Experience with a Novel Perfusion Balloon Catheter in CAP]]>SCAI experts Drs. Cindy Grines, David Kandzari, Annapoorna Kini, and Mohammad Alqarqaz discuss findings from this original research study. Watch to hear about the clinical experience and outcomes from "The Ringer Study," which evaluates a novel perfusion balloon catheter in coronary artery perforation (CAP) cases. Learn how this innovative device may impact procedural safety and patient care in interventional cardiology.Read the full article here: https://www.jscai.org/article/S2772-9303(25)01017-8/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/The-Ringer-Study-Clinical-Experience-with-a-Novel-Perfusion-Balloon-Catheter-in-CAP-e3bdbm9d10cd3a5-1e2b-41e1-bfa6-ef8ec75191e5Mon, 24 Nov 2025 16:53:11 GMT<p>SCAI experts Drs. Cindy Grines, David Kandzari, Annapoorna Kini, and Mohammad Alqarqaz discuss findings from this original research study. Watch to hear about the clinical experience and outcomes from "The Ringer Study," which evaluates a novel perfusion balloon catheter in coronary artery perforation (CAP) cases. Learn how this innovative device may impact procedural safety and patient care in interventional cardiology.Read the full article here: https://www.jscai.org/article/S2772-9303(25)01017-8/fulltext</p> no00:24:37The Ringer Study: Clinical Experience with a Novel Perfusion Balloon Catheter in CAPfull<![CDATA[Variability in State-Level Regulations Regarding Occupational Radiation Exposure]]>Andrew Goldsweig, MD, MSc, FSCAI, Amit Vora, MD, MPH, FSCAI, Sunil Rao, MD, MSCAI, Michele D. Voeltz, MD, highlight key findings from the paper on "Variability in State-Level Regulations Regarding Occupational Radiation Exposure." The discussion emphasized the wide variability in state requirements for shielding, dose monitoring, and safety training, despite uniform federal exposure limits. The panelists underscore the need for a centralized, accessible resource to guide institutions in improving radiation protection practices and reducing occupational risk.Read the article in JSCAI: https://www.jscai.org/article/S2772-9303(25)01039-7/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Variability-in-State-Level-Regulations-Regarding-Occupational-Radiation-Exposure-e3ap3kj2dd0d619-3634-49b9-a3b7-27d98ce362b8Mon, 10 Nov 2025 17:34:14 GMT<p>Andrew Goldsweig, MD, MSc, FSCAI, Amit Vora, MD, MPH, FSCAI, Sunil Rao, MD, MSCAI, Michele D. Voeltz, MD, highlight key findings from the paper on "Variability in State-Level Regulations Regarding Occupational Radiation Exposure." The discussion emphasized the wide variability in state requirements for shielding, dose monitoring, and safety training, despite uniform federal exposure limits. The panelists underscore the need for a centralized, accessible resource to guide institutions in improving radiation protection practices and reducing occupational risk.Read the article in JSCAI: https://www.jscai.org/article/S2772-9303(25)01039-7/fulltext</p> no00:17:38Variability in State-Level Regulations Regarding Occupational Radiation Exposurefull<![CDATA[Coronary Compliance Modification IVL: New Predictor of Stent Expansion in Calcified Coronary Lesions]]>In this video interview, Daniel Chamié, Federico Oliveri, and Ziad Ali discuss key findings from the JSCAI article highlighting how intravascular lithotripsy improves coronary artery compliance and predicts stent expansion in heavily calcified lesions.Read the article: https://doi.org/10.1016/j.jscai.2025.102635

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Coronary-Compliance-Modification-IVL-New-Predictor-of-Stent-Expansion-in-Calcified-Coronary-Lesions-e3a5sod2deb7da0-ae75-48e6-8e0b-38344ee172cbTue, 28 Oct 2025 16:53:24 GMT<p>In this video interview, Daniel Chamié, Federico Oliveri, and Ziad Ali discuss key findings from the JSCAI article highlighting how intravascular lithotripsy improves coronary artery compliance and predicts stent expansion in heavily calcified lesions.Read the article: <a href="https://doi.org/10.1016/j.jscai.2025.102635" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102635</a></p> no00:30:56Coronary Compliance Modification IVL: New Predictor of Stent Expansion in Calcified Coronary Lesionsfull<![CDATA[Outcomes in Patients with PE Treated with Mechanical Thrombectomy or Anticoagulation Alone]]>Sahil Parikh, Hassan Saleh, Peter Monteleone, and Kenneth Rosenfield discuss new data on the use of mechanical thrombectomy for pulmonary embolism. The discussion highlights how these findings may shape patient selection and treatment strategies in managing PE.Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102611

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Outcomes-in-Patients-with-PE-Treated-with-Mechanical-Thrombectomy-or-Anticoagulation-Alone-e3a5rg7816d929a-0ff5-4ca6-8bbc-ebd292132130Tue, 28 Oct 2025 16:26:04 GMT<p>Sahil Parikh, Hassan Saleh, Peter Monteleone, and Kenneth Rosenfield discuss new data on the use of mechanical thrombectomy for pulmonary embolism. The discussion highlights how these findings may shape patient selection and treatment strategies in managing PE.Read the article in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2025.102611" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102611</a></p> no00:19:28Outcomes in Patients with PE Treated with Mechanical Thrombectomy or Anticoagulation Alonefull<![CDATA[High-Definition IVUS vs OCT: Lumen Size and Plaque Morphology]]>Drs. Daniel Chamié, Yiannis Chatzizisis, Natalia Pinilla-Echeverri, Thomas Johnson, and Evan Shlofmitz discuss the role of HD IVUS and OCT in complex coronary interventions, highlighting key differences between the two technologies and how these insights can guide imaging strategies and enhance clinical decision-making.


Read the article in JSCAI: https://www.jscai.org/article/S2772-9303(24)02209-9/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/High-Definition-IVUS-vs-OCT-Lumen-Size-and-Plaque-Morphology-e39pf67e91a19c4-0a87-4cce-be85-a1b5490d14b4Mon, 20 Oct 2025 13:47:57 GMT<p>Drs. Daniel Chamié, Yiannis Chatzizisis, Natalia Pinilla-Echeverri, Thomas Johnson, and Evan Shlofmitz discuss the role of HD IVUS and OCT in complex coronary interventions, highlighting key differences between the two technologies and how these insights can guide imaging strategies and enhance clinical decision-making.</p><p><br /></p><p>Read the article in JSCAI: <a href="https://www.jscai.org/article/S2772-9303(24)02209-9/fulltext" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/article/S2772-9303(24)02209-9/fulltext</a></p> no00:20:50High-Definition IVUS vs OCT: Lumen Size and Plaque Morphologyfull<![CDATA[Cost-Utility Analysis of Endovascular Ultrasound Renal Denervation for Resistant Hypertension in USA]]>In this video, the authors of the study discuss the cost-effectiveness of ultrasound renal denervation (uRDN) for resistant hypertension in the United States. They explore how uRDN, when added to standard care, improves quality-adjusted life years and reduces cardiovascular risks at a favorable cost per QALY.SCAI Experts, Drs. Suzanne Baron, Rod Taylor, and Ajay Kirtane discuss the highlights from this original research article. Read the JSCAI article here: https://www.jscai.org/article/S2772-9303(25)01043-9/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Cost-Utility-Analysis-of-Endovascular-Ultrasound-Renal-Denervation-for-Resistant-Hypertension-in-USA-e395vqe6d760269-8f8b-4fa5-b1cc-711386aa8815Mon, 06 Oct 2025 19:05:13 GMT<p>In this video, the authors of the study discuss the cost-effectiveness of ultrasound renal denervation (uRDN) for resistant hypertension in the United States. They explore how uRDN, when added to standard care, improves quality-adjusted life years and reduces cardiovascular risks at a favorable cost per QALY.SCAI Experts, Drs. Suzanne Baron, Rod Taylor, and Ajay Kirtane discuss the highlights from this original research article. Read the JSCAI article here: <a href="https://www.jscai.org/article/S2772-9303(25)01043-9/fulltext" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/article/S2772-9303(25)01043-9/fulltext</a></p> no00:21:48Cost-Utility Analysis of Endovascular Ultrasound Renal Denervation for Resistant Hypertension in USAfull<![CDATA[SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women]]>This interview with Drs Sandeep Nathan, Suzanne Baron, Mir B. Basir, Mirvat Alasnag highlight the consensus statement addressing sex-based disparities in cardiogenic shock care. Experts discuss the current state of treatment for women, gaps in evidence, and priorities for improving outcomes, offering practical insights and guidance for practice. Read the article published in JSCAI: https://www.jscai.org/article/S2772-9303(24)01373-5/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAIEAPCIACVC-Expert-Consensus-Statement-on-Cardiogenic-Shock-in-Women-e38ah0fc84e0c99-6df9-4c91-bf1f-869fa343a26bThu, 18 Sep 2025 17:57:23 GMT<p>This interview with Drs Sandeep Nathan, Suzanne Baron, Mir B. Basir, Mirvat Alasnag highlight the consensus statement addressing sex-based disparities in cardiogenic shock care. Experts discuss the current state of treatment for women, gaps in evidence, and priorities for improving outcomes, offering practical insights and guidance for practice. Read the article published in JSCAI: <a href="https://www.jscai.org/article/S2772-9303(24)01373-5/fulltext" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/article/S2772-9303(24)01373-5/fulltext</a></p> no00:17:51SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Womenfull<![CDATA[Long-Term Outcome of Percutaneous Coronary Intervention Using Absorb Bioresorbable Scaffold: A SCAAR Study]]>This conversation explores a nationwide Swedish study comparing Absorb bioresorbable scaffolds to drug-eluting stents in over 1,900 patients. While early complications were higher with scaffolds, long-term results suggest potential benefits including lower heart attack rates after three years.


SCAI Experts, Drs. Dean Kereiakes, Saman Saidi-Seresht, Patrick Serruys, and Gregg Stone discuss the highlights from this original research article.


Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103724

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Long-Term-Outcome-of-Percutaneous-Coronary-Intervention-Using-Absorb-Bioresorbable-Scaffold-A-SCAAR-Study-e36qflua85909f6-dcc9-4946-839b-df2d5389c785Tue, 29 Jul 2025 13:00:00 GMT<p>This conversation explores a nationwide Swedish study comparing Absorb bioresorbable scaffolds to drug-eluting stents in over 1,900 patients. While early complications were higher with scaffolds, long-term results suggest potential benefits including lower heart attack rates after three years.</p><p><br /></p><p>SCAI Experts, Drs. Dean Kereiakes, Saman Saidi-Seresht, Patrick Serruys, and Gregg Stone discuss the highlights from this original research article. </p><p><br /></p><p>Read the JSCAI article: <a href="https://doi.org/10.1016/j.jscai.2025.103724" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.103724</a></p> no00:30:26Long-Term Outcome of Percutaneous Coronary Intervention Using Absorb Bioresorbable Scaffold: A SCAAR Studyfull<![CDATA[Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway]]>The global Optimize PRO study shows that using a standardized TAVR care pathway and cusp overlap technique with Evolut PRO/PRO+ valves led to low pacemaker rates, no moderate/severe aortic regurgitation, and favorable 30-day outcomes. SCAI Experts, Drs. Suzanne Baron, Steven Yakubov, John Forrest, and Mayra Guerrero discuss the highlights from this original research article.


Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103515

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Global-Results-From-the-Optimize-PRO-Study-Standardized-TAVR-Technique-and-Care-Pathway-e36qf4r5fd44ec8-4526-47fb-aa10-dba94292a1c9Tue, 29 Jul 2025 13:00:00 GMT<p>The global Optimize PRO study shows that using a standardized TAVR care pathway and cusp overlap technique with Evolut PRO/PRO+ valves led to low pacemaker rates, no moderate/severe aortic regurgitation, and favorable 30-day outcomes. SCAI Experts, Drs. Suzanne Baron, Steven Yakubov, John Forrest, and Mayra Guerrero discuss the highlights from this original research article. </p><p><br /></p><p>Read the JSCAI article: <a href="https://doi.org/10.1016/j.jscai.2025.103515" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.103515</a></p> no00:19:23Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathwayfull<![CDATA[2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Disease]]>Drs. Sahil Parikh, Robert Attaran, Pamela Kim, and Jeff Carr discuss the newly released SCAI guidelines on chronic venous disease (CVD), highlighting key takeaways from the comprehensive review. They discuss the clinical rationale behind the evidence-based recommendations, including guidance on compression therapy, vein ablation, and revascularization strategies. The panel also explores the decision-making algorithms developed to streamline treatment and areas where further research is urgently needed.Read the JSCAI article: https://doi.org/10.1016/j.jscai.2025.103729

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/2025-SCAI-Clinical-Practice-Guidelines-for-the-Management-of-Chronic-Venous-Disease-e35tstaee03a9db-6970-47d9-9f05-22b61adc15d8Wed, 23 Jul 2025 14:17:38 GMT<p>Drs. Sahil Parikh, Robert Attaran, Pamela Kim, and Jeff Carr discuss the newly released SCAI guidelines on chronic venous disease (CVD), highlighting key takeaways from the comprehensive review. They discuss the clinical rationale behind the evidence-based recommendations, including guidance on compression therapy, vein ablation, and revascularization strategies. The panel also explores the decision-making algorithms developed to streamline treatment and areas where further research is urgently needed.Read the JSCAI article: <a href="https://doi.org/10.1016/j.jscai.2025.103729" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.103729</a></p> no00:14:132025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Diseasefull<![CDATA[AI in Training and Education - JSCAI Special Issue: The Role of AI in Cardiovascular Interventions]]>Yiannis Chatzizisis, Guest Editor of JSCAI's Special Issue on The Role of AI in Cardiovascular Interventions, moderates this interview exploring the intersection of interventional cardiology (IC) training, education, and artificial intelligence. The discussion centers around three featured papers from the special issue, authored by Drs. Saurav Chatterjee, Saumya Nanda, Amanda DeVos, and Trevor Simard, each highlighting innovative applications of AI in the education and training of cardiovascular specialists:1- Evaluating AI's Ability to Address Nuanced Cardiology Subspecialty Questions: ChatGPT and CathSAPhttps://doi.org/10.1016/j.jscai.2025.1025632- Development of an Educational Application of Multi-modal Imaging of Clinically Implanted and Bifurcation Stenting Procedureshttps://doi.org/10.1016/j.jscai.2024.1024993- Virtual Reality Simulation with Integrated Passive Haptics Prototype for Cardiac Catheterization Laboratory Traininghttps://doi.org/10.1016/j.jscai.2024.102451

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/AI-in-Training-and-Education---JSCAI-Special-Issue-The-Role-of-AI-in-Cardiovascular-Interventions-e36qu6rd3759b77-6850-4da5-9a02-b614fa8cec80Wed, 16 Jul 2025 13:00:00 GMT<p>Yiannis Chatzizisis, Guest Editor of JSCAI's Special Issue on The Role of AI in Cardiovascular Interventions, moderates this interview exploring the intersection of interventional cardiology (IC) training, education, and artificial intelligence. The discussion centers around three featured papers from the special issue, authored by Drs. Saurav Chatterjee, Saumya Nanda, Amanda DeVos, and Trevor Simard, each highlighting innovative applications of AI in the education and training of cardiovascular specialists:1- Evaluating AI's Ability to Address Nuanced Cardiology Subspecialty Questions: ChatGPT and CathSAP<a href="https://doi.org/10.1016/j.jscai.2025.102563" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102563</a>2- Development of an Educational Application of Multi-modal Imaging of Clinically Implanted and Bifurcation Stenting Procedures<a href="https://doi.org/10.1016/j.jscai.2024.102499" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102499</a>3- Virtual Reality Simulation with Integrated Passive Haptics Prototype for Cardiac Catheterization Laboratory Training<a href="https://doi.org/10.1016/j.jscai.2024.102451" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102451</a></p> no00:26:17AI in Training and Education - JSCAI Special Issue: The Role of AI in Cardiovascular Interventionsfull<![CDATA[Safety & Feasibility of the RevCore Catheter for Venous In-Stent Thrombosis]]>Experts, Sahil Parikh, Abdullah Shaikh, Steven Abramowitz, and Hillary Johnston-Cox discuss this study published in JSCAI, highlighting its contribution to the evolving management of venous in-stent thrombosis. This multicenter retrospective analysis evaluated the safety and feasibility of the RevCore thrombectomy catheter, demonstrating technical success with no device-related serious adverse events and 94% patency at first follow-up.Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102571

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Safety--Feasibility-of-the-RevCore-Catheter-for-Venous-In-Stent-Thrombosis-e35cq5dffa31473-e1df-4ec3-93e3-09b6557ff674Thu, 10 Jul 2025 17:12:19 GMT<p>Experts, Sahil Parikh, Abdullah Shaikh, Steven Abramowitz, and Hillary Johnston-Cox discuss this study published in JSCAI, highlighting its contribution to the evolving management of venous in-stent thrombosis. This multicenter retrospective analysis evaluated the safety and feasibility of the RevCore thrombectomy catheter, demonstrating technical success with no device-related serious adverse events and 94% patency at first follow-up.Read the article in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2025.102571" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102571</a></p> no00:21:37Safety & Feasibility of the RevCore Catheter for Venous In-Stent Thrombosisfull<![CDATA[Pioneers in IC: History of Pediatric Interventional Fellowship Training]]>Beginning in the late 1970s and early 1980s, the origins of congenital heart disease (CHD) interventional fellowship training can be traced to five seminal pioneers: Charles Mullins, James Lock, William E. Hellenbrand, Lee N. Benson, and Albert P. Rocchini. The vast majority of CHD interventional cardiologists with formal training can trace their learning lineage back to this group. In the video, listen to William E. Hellenbrand, MD, MSCAI; Lee N. Benson, MD, MSCAI; Albert P. Rocchini, MD; and Frank F. Ing, MD, MSCAI, as they discuss how each of their programs began. The accompanying article in JSCAI features tributes to each of the five pioneers, written by their former fellows. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.103707

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Pioneers-in-IC-History-of-Pediatric-Interventional-Fellowship-Training-e33efol59e64f3a-3d6f-4d0b-8c87-3294a9b0de7eTue, 27 May 2025 13:00:00 GMT<p>Beginning in the late 1970s and early 1980s, the origins of congenital heart disease (CHD) interventional fellowship training can be traced to five seminal pioneers: Charles Mullins, James Lock, William E. Hellenbrand, Lee N. Benson, and Albert P. Rocchini. The vast majority of CHD interventional cardiologists with formal training can trace their learning lineage back to this group. In the video, listen to William E. Hellenbrand, MD, MSCAI; Lee N. Benson, MD, MSCAI; Albert P. Rocchini, MD; and Frank F. Ing, MD, MSCAI, as they discuss how each of their programs began. The accompanying article in JSCAI features tributes to each of the five pioneers, written by their former fellows. Read the article in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2025.103707" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.103707</a></p> no00:46:29Pioneers in IC: History of Pediatric Interventional Fellowship Trainingfull<![CDATA[SCAI Expert Consensus Statement on Alternative Access for TAVR]]>Sandeep Nathan, MD, MSc, FACC, FSCAI, Matthew Sherwood, MD, FSCAI, Kendra Grubb, MD, Adam Greenbaum, MD, FSCAI discuss the SCAI Expert Consensus Statement published in JSCAI. The panel provides an insightful overview of the expert consensus, highlighting that alternative access is essential for a small subset of TAVR patients. It emphasizes the most effective techniques, the importance of a collaborative, multidisciplinary approach in patient selection, and the need to recognize institutional resources and operator capabilities for optimal patient outcomes. Additionally, the panel explores how cutting-edge advancements in device technology and imaging are revolutionizing the safety and precision of alternative access TAVR procedures, enhancing both patient care and procedural success.Read the article: https://doi.org/10.1016/j.jscai.2024.102514

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-Alternative-Access-for-TAVR-e32usmu2ae88801-eb29-475a-9752-6d76e4d6bcc2Fri, 16 May 2025 19:00:00 GMT<p>Sandeep Nathan, MD, MSc, FACC, FSCAI, Matthew Sherwood, MD, FSCAI, Kendra Grubb, MD, Adam Greenbaum, MD, FSCAI discuss the SCAI Expert Consensus Statement published in JSCAI. The panel provides an insightful overview of the expert consensus, highlighting that alternative access is essential for a small subset of TAVR patients. It emphasizes the most effective techniques, the importance of a collaborative, multidisciplinary approach in patient selection, and the need to recognize institutional resources and operator capabilities for optimal patient outcomes. Additionally, the panel explores how cutting-edge advancements in device technology and imaging are revolutionizing the safety and precision of alternative access TAVR procedures, enhancing both patient care and procedural success.Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102514" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102514</a></p> no00:18:06SCAI Expert Consensus Statement on Alternative Access for TAVRfull<![CDATA[AI in Congenital Heart Disease: JSCAI Special Issue on the Role of AI in Cardiovascular Interventions]]>In two landmark articles published in the JSCAI, leading experts Elazer R. Edelman, MD, PhD, Michael Taylor, MD, PhD, Brian Quinn, MD, and Kathy Jenkins, MD, MPH discuss the transformative potential of artificial intelligence (AI) in pediatric and congenital cardiac care. Read the related articles:

The Role of AI in CHD and Interventions: https://doi.org/10.1016/j.jscai.2025.102567 Generating Risk Reduction Analytics in Complex Cardiac Care Environments: https://doi.org/10.1016/j.jscai.2024.102434

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/AI-in-Congenital-Heart-Disease-JSCAI-Special-Issue-on-the-Role-of-AI-in-Cardiovascular-Interventions-e32t8b0867b0357-25b5-46b1-8ba4-d40f0ba54a01Thu, 15 May 2025 18:03:04 GMT<p>In two landmark articles published in the JSCAI, leading experts Elazer R. Edelman, MD, PhD, Michael Taylor, MD, PhD, Brian Quinn, MD, and Kathy Jenkins, MD, MPH discuss the transformative potential of artificial intelligence (AI) in pediatric and congenital cardiac care. Read the related articles:</p><p>The Role of AI in CHD and Interventions: <a href="https://doi.org/10.1016/j.jscai.2025.102567 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102567 </a>Generating Risk Reduction Analytics in Complex Cardiac Care Environments: <a href="https://doi.org/10.1016/j.jscai.2024.102434" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102434</a></p> no00:22:32AI in Congenital Heart Disease: JSCAI Special Issue on the Role of AI in Cardiovascular Interventionsfull<![CDATA[AI in Coronary Intervention Planning & Outcome Prediction]]>Yiannis Chatzizisis, MD, PhD, FSCAI, Zain Khalpey, MD, PhD, FACS, Robert Herman, and Karley B. Fischer, MD discuss 4 articles published in JSCAIs special issue on "The Role of Artificial Intelligence in Cardiovascular Interventions". Watch the video conversation on AI and Coronary procedural planning and read the related articles below: Enhancing Diagnostic Accuracy and Procedural Outcomes in Interventional Cardiology Through Machine Learning Algorithms: https://doi.org/10.1016/j.jscai.2024.102511 AI in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance: https://doi.org/10.1016/j.jscai.2024.102519 Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale: https://doi.org/10.1016/j.jscai.2024.102494 Effects of Artificial Intelligence Clinical Decision Support Tools on Complications Following Percutaneous Coronary Intervention: https://doi.org/10.1016/j.jscai.2024.102497

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/AI-in-Coronary-Intervention-Planning--Outcome-Prediction-e32rfroef5b3146-4bb0-40c2-97f3-7af664f8f9d2Wed, 14 May 2025 17:00:52 GMT<p>Yiannis Chatzizisis, MD, PhD, FSCAI, Zain Khalpey, MD, PhD, FACS, Robert Herman, and Karley B. Fischer, MD discuss 4 articles published in JSCAIs special issue on "The Role of Artificial Intelligence in Cardiovascular Interventions". Watch the video conversation on AI and Coronary procedural planning and read the related articles below: Enhancing Diagnostic Accuracy and Procedural Outcomes in Interventional Cardiology Through Machine Learning Algorithms: <a href="https://doi.org/10.1016/j.jscai.2024.102511 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102511 </a>AI in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance: <a href="https://doi.org/10.1016/j.jscai.2024.102519 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102519 </a>Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale: <a href="https://doi.org/10.1016/j.jscai.2024.102494 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102494 </a>Effects of Artificial Intelligence Clinical Decision Support Tools on Complications Following Percutaneous Coronary Intervention: <a href="https://doi.org/10.1016/j.jscai.2024.102497" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102497</a></p> no00:44:12AI in Coronary Intervention Planning & Outcome Predictionfull<![CDATA[Coronary Computed Tomography Angiography to Guide PCI: Expert Opinion from SCAI / SCCT Roundtable]]>Jonathon Leipsic, Yader Sandoval, Koen Nieman, Natalia Pinilla, and Hector Garcia discussed the significance & highlights from the CCTA roundtable document. The panel emphasized the use of CCTA to enhance pre-procedural planning, improve patient outcomes, and optimize resource utilization by providing detailed anatomical and functional assessments of coronary lesions. The experts also highlighted the roundtable's recommendations, which included increasing access to contemporary CCTA scanners, enhancing visualization tools for interventionalists, and promoting educational training efforts. Read the article: https://doi.org/10.1016/j.jscai.2025.103664

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Coronary-Computed-Tomography-Angiography-to-Guide-PCI-Expert-Opinion-from-SCAI--SCCT-Roundtable-e3287qac376afed-6357-48b1-aebb-e00454ce1cfdThu, 01 May 2025 12:24:02 GMT<p>Jonathon Leipsic, Yader Sandoval, Koen Nieman, Natalia Pinilla, and Hector Garcia discussed the significance &amp; highlights from the CCTA roundtable document. The panel emphasized the use of CCTA to enhance pre-procedural planning, improve patient outcomes, and optimize resource utilization by providing detailed anatomical and functional assessments of coronary lesions. The experts also highlighted the roundtable's recommendations, which included increasing access to contemporary CCTA scanners, enhancing visualization tools for interventionalists, and promoting educational training efforts. Read the article: <a href="https://doi.org/10.1016/j.jscai.2025.103664" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.103664</a></p> no00:20:54Coronary Computed Tomography Angiography to Guide PCI: Expert Opinion from SCAI / SCCT Roundtablefull<![CDATA[AI in Innovation & Governance: JSCAI Special Issue on the Role of AI in Cardiovascular Interventions]]>Elazar Edelman, MD, PhD, Rohan Khera MD, MS, Afnan Tariq, MD, JD, FSCAI, & Curtis Rooney discuss 2 articles published in JSCAI's latest issue. This video interview focuses on its role in optimizing patient care, preserving physician autonomy, and addressing algorithmic bias. The panel also dives into the ethical, regulatory, and practical considerations of AI integration, highlighting the importance of societies in advocating for education and promoting transparent, equitable, and secure AI-driven decision-making systems.1- Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care: https://doi.org/10.1016/j.jscai.2025.102562 2- Governing the Unbound: SCAI’s Role in the Future of Artificial Intelligence: https://doi.org/10.1016/j.jscai.2024.102517Read the special issue:

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/AI-in-Innovation--Governance-JSCAI-Special-Issue-on-the-Role-of-AI-in-Cardiovascular-Interventions-e31s1lt505ea602-3316-49bb-89c0-c1a086a2675dTue, 22 Apr 2025 17:50:20 GMT<p>Elazar Edelman, MD, PhD, Rohan Khera MD, MS, Afnan Tariq, MD, JD, FSCAI, &amp; Curtis Rooney discuss 2 articles published in JSCAI's latest issue. This video interview focuses on its role in optimizing patient care, preserving physician autonomy, and addressing algorithmic bias. The panel also dives into the ethical, regulatory, and practical considerations of AI integration, highlighting the importance of societies in advocating for education and promoting transparent, equitable, and secure AI-driven decision-making systems.1- Harnessing Artificial Intelligence for Innovation in Interventional Cardiovascular Care: <a href="https://doi.org/10.1016/j.jscai.2025.102562 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102562 </a>2- Governing the Unbound: SCAI’s Role in the Future of Artificial Intelligence: <a href="https://doi.org/10.1016/j.jscai.2024.102517" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102517</a>Read the special issue: </p> no00:15:19AI in Innovation & Governance: JSCAI Special Issue on the Role of AI in Cardiovascular Interventionsfull<![CDATA[The Impact of IVUS Use on 1-Yr Outcomes after Infrapopliteal Endovascular Intervention]]>Andrew Goldsweig, Daniel Snyder, Sahil Parikh, and Herb Aronow discuss the highlights from an original research paper published in JSCAI. The study aimed to evaluate the association between intravascular ultrasound (IVUS) use and 1-year outcomes after infrapopliteal intervention. The authors found that IVUS utilization significantly reduced rates of binary restenosis and target lesion revascularization compared to angiography alone, without affecting rates of amputation, major adverse limb events, or mortality. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2024.102509

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/The-Impact-of-IVUS-Use-on-1-Yr-Outcomes-after-Infrapopliteal-Endovascular-Intervention-e31qepp2066ef04-4500-4670-bbc9-275c344c06f0Mon, 21 Apr 2025 18:20:51 GMT<p>Andrew Goldsweig, Daniel Snyder, Sahil Parikh, and Herb Aronow discuss the highlights from an original research paper published in JSCAI. The study aimed to evaluate the association between intravascular ultrasound (IVUS) use and 1-year outcomes after infrapopliteal intervention. The authors found that IVUS utilization significantly reduced rates of binary restenosis and target lesion revascularization compared to angiography alone, without affecting rates of amputation, major adverse limb events, or mortality. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2024.102509</p> no00:21:37The Impact of IVUS Use on 1-Yr Outcomes after Infrapopliteal Endovascular Interventionfull<![CDATA[AI in Cardiovascular Imaging: JSCAI Special Issue on the Role of AI in Cardiovascular Interventions]]>Yiannis Chatzizisis, Maryam Alsharqi, Evan Shlofmitz, Daniel Chamié discuss three important papers published in the JSCAI special issue. The panel explores advancements in intravascular imaging (IVI) technologies, the latest research, the current landscape of AI applications, and the educational needs to bridge practice gaps. The discussion highlights how AI-driven tools can be leveraged for PCI planning, including lesion assessment, procedural optimization, and workflow efficiency to enhance patient outcomes.1- Artificial Intelligence in Cardiovascular Imaging and Interventional Cardiology: Emerging Trends and Clinical Implications: https://doi.org/10.1016/j.jscai.2024.1025582- Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision: https://doi.org/10.1016/j.jscai.2024.102506 3-Can AI Capture and Quantify Clinical Expertise? Implications for Intracoronary Imaging in Percutaneous Coronary Intervention: https://doi.org/10.1016/j.jscai.2024.102523Read the issue: https://www.jscai.org/issue/S2772-9303(25)X0003-X

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/AI-in-Cardiovascular-Imaging-JSCAI-Special-Issue-on-the-Role-of-AI-in-Cardiovascular-Interventions-e31n76lc1f8f133-17c8-46f6-a2bc-894d16e47b07Fri, 18 Apr 2025 19:07:23 GMT<p>Yiannis Chatzizisis, Maryam Alsharqi, Evan Shlofmitz, Daniel Chamié discuss three important papers published in the JSCAI special issue. The panel explores advancements in intravascular imaging (IVI) technologies, the latest research, the current landscape of AI applications, and the educational needs to bridge practice gaps. The discussion highlights how AI-driven tools can be leveraged for PCI planning, including lesion assessment, procedural optimization, and workflow efficiency to enhance patient outcomes.1- Artificial Intelligence in Cardiovascular Imaging and Interventional Cardiology: Emerging Trends and Clinical Implications: <a href="https://doi.org/10.1016/j.jscai.2024.102558" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102558</a>2- Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision: <a href="https://doi.org/10.1016/j.jscai.2024.102506 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102506 </a>3-Can AI Capture and Quantify Clinical Expertise? Implications for Intracoronary Imaging in Percutaneous Coronary Intervention: <a href="https://doi.org/10.1016/j.jscai.2024.102523" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102523</a>Read the issue: <a href="https://www.jscai.org/issue/S2772-9303(25)X0003-X" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/issue/S2772-9303(25)X0003-X</a></p> no00:38:35AI in Cardiovascular Imaging: JSCAI Special Issue on the Role of AI in Cardiovascular Interventionsfull<![CDATA[New Covered Stent Design for Correcting Sinus Venosus Defects & Novel Deployment Technique]]>Discover the latest in transcatheter correction for sinus venosus defects. The authors innovative approach utilizes balloon-expandable covered stents across the cavoatrial junction to effectively redirect the anomalous right upper pulmonary vein to the left atrium. Drs. Frank Ing, Kothandam Sivakumar, Eric Rosenthal, and Shakeel Qureshi discuss the highlights from the case series. Read the article: https://doi.org/10.1016/j.jscai.2024.102501

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/New-Covered-Stent-Design-for-Correcting-Sinus-Venosus-Defects--Novel-Deployment-Technique-e31kgo3081a9e36-9377-4912-b8c1-2f82ba9b9be0Wed, 16 Apr 2025 19:00:42 GMT<p>Discover the latest in transcatheter correction for sinus venosus defects. The authors innovative approach utilizes balloon-expandable covered stents across the cavoatrial junction to effectively redirect the anomalous right upper pulmonary vein to the left atrium. Drs. Frank Ing, Kothandam Sivakumar, Eric Rosenthal, and Shakeel Qureshi discuss the highlights from the case series. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102501" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102501</a></p> no00:36:09New Covered Stent Design for Correcting Sinus Venosus Defects & Novel Deployment Techniquefull<![CDATA[Novel Mechanical Aspiration Thrombectomy in Patients with Acute Pulmonary Embolism: APEX-AV Trial]]>APEX-AV trial evaluated the safety and efficacy of the AlphaVac F1885 System for treating acute intermediate-risk pulmonary embolism (PE). The study found significant reductions in the right ventricular/left ventricular diameter ratio and pulmonary arterial pressure within 48 hours post-procedure, along with a 35.5% mean reduction in clot burden. The treatment demonstrated a low rate of major adverse events, primarily minor access site bleeding. Drs. Sahil Parikh, Mona Ranade, William Brent Keeling, and Kenneth Rosenfield discuss the trial highlights in this video interview. Read the article: https://doi.org/10.1016/j.jscai.2024.102463

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Novel-Mechanical-Aspiration-Thrombectomy-in-Patients-with-Acute-Pulmonary-Embolism-APEX-AV-Trial-e31k9so2b46df97-7564-4d58-982e-5d203ed6a864Wed, 16 Apr 2025 16:39:34 GMT<p>APEX-AV trial evaluated the safety and efficacy of the AlphaVac F1885 System for treating acute intermediate-risk pulmonary embolism (PE). The study found significant reductions in the right ventricular/left ventricular diameter ratio and pulmonary arterial pressure within 48 hours post-procedure, along with a 35.5% mean reduction in clot burden. The treatment demonstrated a low rate of major adverse events, primarily minor access site bleeding. Drs. Sahil Parikh, Mona Ranade, William Brent Keeling, and Kenneth Rosenfield discuss the trial highlights in this video interview. Read the article: <a href=" https://doi.org/10.1016/j.jscai.2024.102463" rel="noopener noreferrer nofollow" target="_blank"> https://doi.org/10.1016/j.jscai.2024.102463</a></p> no00:17:45Novel Mechanical Aspiration Thrombectomy in Patients with Acute Pulmonary Embolism: APEX-AV Trialfull<![CDATA[Occupational Health Hazards in the Cardiac Catheterization Laboratory: 2023 SCAI Survey]]>SCAI Leaders—Dr. David Rizik, Dr. James Hermiller, Dr. Andrew Klein, and Dr. Islam Abudayyeh—explore the significant hazards faced by interventional cardiologists in the catheterization lab (CCL), including radiation exposure, orthopedic injuries, and the physical and psychological stress associated with the profession. They also emphasize the moral imperative to improve workplace safety, advocating for systemic changes that prioritize physician well-being, enhance long-term career sustainability, and ultimately improve patient care.Read the related JSCAI article: https://doi.org/10.1016/j.jscai.2024.102493

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Occupational-Health-Hazards-in-the-Cardiac-Catheterization-Laboratory-2023-SCAI-Survey-e311dpm30fe9058-4405-4822-8074-e0952961f276Wed, 02 Apr 2025 22:56:30 GMT<p>SCAI Leaders—Dr. David Rizik, Dr. James Hermiller, Dr. Andrew Klein, and Dr. Islam Abudayyeh—explore the significant hazards faced by interventional cardiologists in the catheterization lab (CCL), including radiation exposure, orthopedic injuries, and the physical and psychological stress associated with the profession. They also emphasize the moral imperative to improve workplace safety, advocating for systemic changes that prioritize physician well-being, enhance long-term career sustainability, and ultimately improve patient care.Read the related JSCAI article: <a href="https://doi.org/10.1016/j.jscai.2024.102493" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102493</a></p> no00:29:42Occupational Health Hazards in the Cardiac Catheterization Laboratory: 2023 SCAI Surveyfull<![CDATA[Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial]]>In this discussion, Suzanne Baron, MD, FSCAI, Zach Gertz, MD, Gregg W. Stone, MD, MSCAI, and Lissa Sugeng, MD, FSCAI, highlight key findings from the JSCAI article on the impact of forward flow in heart failure (HF) patients undergoing mitral transcatheter edge-to-edge repair (TEER). The panel discusses data from the COAPT trial, which stratified patients by baseline forward flow and assessed outcomes with TEER plus guideline-directed medical therapy (GDMT) versus GDMT alone. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102609

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Forward-Flow-in-Patients-with-Heart-Failure-and-Functional-Mitral-Regurgitation-The-COAPT-Trial-e30mtamffb03456-30aa-47e6-8f00-f4b38bef0d89Thu, 27 Mar 2025 17:00:00 GMT<p>In this discussion, Suzanne Baron, MD, FSCAI, Zach Gertz, MD, Gregg W. Stone, MD, MSCAI, and Lissa Sugeng, MD, FSCAI, highlight key findings from the JSCAI article on the impact of forward flow in heart failure (HF) patients undergoing mitral transcatheter edge-to-edge repair (TEER). The panel discusses data from the COAPT trial, which stratified patients by baseline forward flow and assessed outcomes with TEER plus guideline-directed medical therapy (GDMT) versus GDMT alone. Read the article in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2025.102609" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2025.102609</a></p> no00:18:50Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trialfull<![CDATA[Percutaneous Mechanical Aspiration for IE: Proceedings from an Inaugural Multidisciplinary Summit]]>The clinical presentation and epidemiology of infective endocarditis (IE) have evolved over time. While the cornerstones of IE treatment remain antimicrobial therapy and surgery, percutaneous mechanical aspiration (PMA) has emerged as an option for carefully selected patients as a complementary modality, based on retrospective data, case series, and expert experience. In this comprehensive review, published in JSCAI, the authors summarize the proceedings from an inaugural summit dedicated to the discussion of PMA in the global management of IE, consisting of experts across multiple disciplines from diverse geographic regions and care environments. This video conversation highlights the comprehensive review with a panel discussion featuring Cindy Grines, MD, MSCAI, Lucas Marinacci, MD, Kenneth Rosenfield, MD, MSc, MSCAI, & Molly Paras, MD.Read the article: https://doi.org/10.1016/j.jscai.2024.102283

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Percutaneous-Mechanical-Aspiration-for-IE-Proceedings-from-an-Inaugural-Multidisciplinary-Summit-e30m06113864b28-5ce4-42c3-b5f4-eb2701669404Wed, 26 Mar 2025 16:52:57 GMT<p>The clinical presentation and epidemiology of infective endocarditis (IE) have evolved over time. While the cornerstones of IE treatment remain antimicrobial therapy and surgery, percutaneous mechanical aspiration (PMA) has emerged as an option for carefully selected patients as a complementary modality, based on retrospective data, case series, and expert experience. In this comprehensive review, published in JSCAI, the authors summarize the proceedings from an inaugural summit dedicated to the discussion of PMA in the global management of IE, consisting of experts across multiple disciplines from diverse geographic regions and care environments. This video conversation highlights the comprehensive review with a panel discussion featuring Cindy Grines, MD, MSCAI, Lucas Marinacci, MD, Kenneth Rosenfield, MD, MSc, MSCAI, &amp; Molly Paras, MD.Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102283" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102283</a></p> no00:24:56Percutaneous Mechanical Aspiration for IE: Proceedings from an Inaugural Multidisciplinary Summitfull<![CDATA[Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover]]>The video panel discussion featuring Cindy Grines, MD, MSCAI, Revathy Sampath-Kumar, MD, Ian Gilchrist, MD, MSCAI, Michel Le May, BSc, MD, and Pradyumna Tummala, MD highlights the findings of the study published in JSCAI. The study found that radial to femoral access-site crossover (RFC) during percutaneous coronary intervention (PCI) was associated with higher short-term mortality and bleeding complications compared to radial access (RA). Independent predictors of RFC included age greater than 70 years, vasopressor support, and dialysis dependence. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2024.102450⁠ 

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Patient-Characteristics-and-Outcomes-of-Radial-to-Femoral-Access-Site-Crossover-e3060du05b57998-1055-4f61-bd3f-0e7aa371c3b5Fri, 14 Mar 2025 13:00:00 GMT<p>The video panel discussion featuring Cindy Grines, MD, MSCAI, Revathy Sampath-Kumar, MD, Ian Gilchrist, MD, MSCAI, Michel Le May, BSc, MD, and Pradyumna Tummala, MD highlights the findings of the study published in JSCAI. The study found that radial to femoral access-site crossover (RFC) during percutaneous coronary intervention (PCI) was associated with higher short-term mortality and bleeding complications compared to radial access (RA). Independent predictors of RFC included age greater than 70 years, vasopressor support, and dialysis dependence. Read the article in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2024.102450⁠" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102450⁠</a> </p> no00:22:15Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossoverfull<![CDATA[Coronary Function Testing: Seeking Answers for Refractory Chest Pain]]>In this video conversation featuring Connor Tice, MD, John Blair, MD, Larry Dean, MD, MSCAI, and Morton Kern, MD, MSCAI, the panel explores the role of coronary function testing in providing diagnostic clarity and potential therapeutic options for patients presenting with angina, despite having nonobstructive coronary arteries on coronary angiography. This discussion highlights key takeaways from the Hemodynamics case report published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2024.102437

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Coronary-Function-Testing-Seeking-Answers-for-Refractory-Chest-Pain-e2v81cb1a375d66-746c-43e1-a236-3cd754669f53Sat, 22 Feb 2025 14:00:00 GMT<p>In this video conversation featuring Connor Tice, MD, John Blair, MD, Larry Dean, MD, MSCAI, and Morton Kern, MD, MSCAI, the panel explores the role of coronary function testing in providing diagnostic clarity and potential therapeutic options for patients presenting with angina, despite having nonobstructive coronary arteries on coronary angiography. This discussion highlights key takeaways from the Hemodynamics case report published in JSCAI. </p><p><br /></p><p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102437" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102437</a></p> no00:34:18Coronary Function Testing: Seeking Answers for Refractory Chest Painfull<![CDATA[Time-Dependent Changes in the Coronary Circulation Triggered by CTO Revascularization]]>Physiological changes in the coronary circulation associated with PCI for CTOs remain largely unknown. This systematic review and meta-analysis, published in JSCAI, aimed to investigate physiological changes in the CTO and donor vessel before and immediately after PCI, as well as at follow-up.Dean Kereiakes MD MSCAI, Javier Escaned MD PhD, Emmanouil Brilakis MD PhD FSCAI, and William Fearon MD FSCAI discuss the article highlights in this video interview. Read the article: https://doi.org/10.1016/j.jscai.2024.102452

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Time-Dependent-Changes-in-the-Coronary-Circulation-Triggered-by-CTO-Revascularization-e319iff1260e1bf-442c-469a-9a8f-3f1e89198330Tue, 18 Feb 2025 14:00:00 GMT<p>Physiological changes in the coronary circulation associated with PCI for CTOs remain largely unknown. This systematic review and meta-analysis, published in JSCAI, aimed to investigate physiological changes in the CTO and donor vessel before and immediately after PCI, as well as at follow-up.Dean Kereiakes MD MSCAI, Javier Escaned MD PhD, Emmanouil Brilakis MD PhD FSCAI, and William Fearon MD FSCAI discuss the article highlights in this video interview. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102452" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102452</a></p> no00:30:19Time-Dependent Changes in the Coronary Circulation Triggered by CTO Revascularizationfull<![CDATA[Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM Study]]>Leaders, Sahil Parikh, MD, FSCAI, Pietro Di Santo, MD, & Carlos Mena-Hurtado, MD FSCAI, discuss key findings from the ULTRAsound Assessment of Access SITe COMplications study, highlighting the superior accuracy of point-of-care ultrasound (POCUS) in detecting pseudoaneurysms compared to physical examination alone. The authors explore how integrating POCUS into routine practice could enhance early complication detection, improving patient outcomes and reducing healthcare costs. With advancements in ultrasound accessibility, this discussion underscores the growing role of POCUS in optimizing post-procedural care.Read the related article: https://doi.org/10.1016/j.jscai.2024.102516

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Point-of-Care-Ultrasound-for-the-Detection-of-Vascular-Access-Site-ComplicationsThe-ULTRASITCOM-Study-e2vvq3f5923956c-6a32-44eb-ba69-f6739f8ea2c5Tue, 18 Feb 2025 14:00:00 GMT<p>Leaders, Sahil Parikh, MD, FSCAI, Pietro Di Santo, MD, &amp; Carlos Mena-Hurtado, MD FSCAI, discuss key findings from the ULTRAsound Assessment of Access SITe COMplications study, highlighting the superior accuracy of point-of-care ultrasound (POCUS) in detecting pseudoaneurysms compared to physical examination alone. The authors explore how integrating POCUS into routine practice could enhance early complication detection, improving patient outcomes and reducing healthcare costs. With advancements in ultrasound accessibility, this discussion underscores the growing role of POCUS in optimizing post-procedural care.Read the related article: <a href="https://doi.org/10.1016/j.jscai.2024.102516" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102516</a></p> no00:19:07Point-of-Care Ultrasound for the Detection of Vascular Access Site Complications—The ULTRASITCOM Studyfull<![CDATA[Comparision of Different PCI Strategies for Coronary DES ISR: A Bayesian Network Analysis]]>A Bayesian network meta-analysis of 30 studies involving 8,016 patients compared 12 PCI strategies for treating DES-ISR. Prakash Raj Oli, MBBS, Andrew Goldsweig, MD, FSCAI, Evan Shlofmitz, DO, discuss these findings in an insightful video interview, emphasizing key clinical takeaways and the need for further research. Read the article: https://doi.org/10.1016/j.jscai.2024.102428

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Comparision-of-Different-PCI-Strategies-for-Coronary-DES-ISR-A-Bayesian-Network-Analysis-e2uc2s66e351bdf-ef9e-4097-bf20-69b099576125Fri, 31 Jan 2025 14:00:00 GMT<p>A Bayesian network meta-analysis of 30 studies involving 8,016 patients compared 12 PCI strategies for treating DES-ISR. Prakash Raj Oli, MBBS, Andrew Goldsweig, MD, FSCAI, Evan Shlofmitz, DO, discuss these findings in an insightful video interview, emphasizing key clinical takeaways and the need for further research. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102428" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102428</a> </p> no00:18:46Comparision of Different PCI Strategies for Coronary DES ISR: A Bayesian Network Analysisfull<![CDATA[Acute Myocardial Infarction and Stage E Shock: Insights From the RECOVER III Study]]>Drs. Andrew Goldsweig, MD, MS, FSCAI, Ivan Hanson, MD, FSCAI, Bill O’Neil, MD, MSCAI, Srihari Naidu, MD, FSCAI & M. Babar Basir, DO, FSCAI discuss this original research in JSCAI highlighting the characteristics and outcomes of the SCAI stage E shock patients with AMICS undergoing PCI who improved to stage C or D within 24 hours of Impella support (“responders”) vs those patients who remained in stage E (“nonresponders”). Read the article: https://doi.org/10.1016/j.jscai.2024.102462

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Acute-Myocardial-Infarction-and-Stage-E-Shock-Insights-From-the-RECOVER-III-Study-e2u5n8oab52b659-fbc4-41e7-a322-0397597d3fe4Wed, 29 Jan 2025 14:00:00 GMT<p>Drs. Andrew Goldsweig, MD, MS, FSCAI, Ivan Hanson, MD, FSCAI, Bill O’Neil, MD, MSCAI, Srihari Naidu, MD, FSCAI &amp; M. Babar Basir, DO, FSCAI discuss this original research in JSCAI highlighting the characteristics and outcomes of the SCAI stage E shock patients with AMICS undergoing PCI who improved to stage C or D within 24 hours of Impella support (“responders”) vs those patients who remained in stage E (“nonresponders”). Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102462" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102462</a> </p> no00:26:39Acute Myocardial Infarction and Stage E Shock: Insights From the RECOVER III Studyfull<![CDATA[Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure]]> In this review, the authors discuss the various aspects of right heart blood flow patterns, as assessed by 4D flow MRI, in the context of shunt devices under clinical evaluation for patients with symptomatic HFpEF. This related video conversation features Andrew M. Goldsweig, MD, MS, FSCAI, Raviteja Guddeti, MD, Megan Coylewright, MD, FSCAI, Sheldon Litwin, MD, Santiago Garcia, MD, FSCAI, and Peter S. Fail, MD, FSCAI. They discuss the importance of using 4-dimensional flow magnetic resonance imaging to examine the abnormal right heart blood flow patterns in naturally occurring interatrial shunts. Read the related article: https://doi.org/10.1016/j.jscai.2024.102439

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Understanding-Right-Heart-Flow-Implications-for-Interatrial-Shunt-Device-Therapy-in-Heart-Failure-e2trg0q74cbe176-1c21-4762-98be-96126e81f041Tue, 21 Jan 2025 14:00:00 GMT<p> In this review, the authors discuss the various aspects of right heart blood flow patterns, as assessed by 4D flow MRI, in the context of shunt devices under clinical evaluation for patients with symptomatic HFpEF. This related video conversation features Andrew M. Goldsweig, MD, MS, FSCAI, Raviteja Guddeti, MD, Megan Coylewright, MD, FSCAI, Sheldon Litwin, MD, Santiago Garcia, MD, FSCAI, and Peter S. Fail, MD, FSCAI. They discuss the importance of using 4-dimensional flow magnetic resonance imaging to examine the abnormal right heart blood flow patterns in naturally occurring interatrial shunts. Read the related article: <a href="https://doi.org/10.1016/j.jscai.2024.102439" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102439</a></p> no00:23:45Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failurefull<![CDATA[Comparison of the Safety & Efficacy of Endovascular Interventions for the Treatment of SFA Disease]]> To evaluate the safety and efficacy of endovascular treatments for superficial femoral artery (SFA) disease, in this network meta-analysis of 57 randomized trials (9089 patients), the authors compared outcomes across nine modalities, including PTA, atherectomy, drug-coated balloons, and stents. The analysis showed superior technical success and 12-month patency for most techniques compared to PTA, with CSG and A+DCB outperforming other interventions, while no significant differences were observed in mortality or major amputation rates. Sahil Parikh, MD, FSCAI, Khanjan Shah, MD, FSCAI, and Andrew Schwartz, BS discuss methods and results in this video interview. Read the article: https://doi.org/10.1016/j.jscai.2024.102432

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Comparison-of-the-Safety--Efficacy-of-Endovascular-Interventions-for-the-Treatment-of-SFA-Disease-e2trg82654b0da1-b609-44bc-a080-0598ea77cad8Tue, 21 Jan 2025 14:00:00 GMT<p> To evaluate the safety and efficacy of endovascular treatments for superficial femoral artery (SFA) disease, in this network meta-analysis of 57 randomized trials (9089 patients), the authors compared outcomes across nine modalities, including PTA, atherectomy, drug-coated balloons, and stents. The analysis showed superior technical success and 12-month patency for most techniques compared to PTA, with CSG and A+DCB outperforming other interventions, while no significant differences were observed in mortality or major amputation rates. Sahil Parikh, MD, FSCAI, Khanjan Shah, MD, FSCAI, and Andrew Schwartz, BS discuss methods and results in this video interview. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102432" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102432</a> </p> no00:16:12Comparison of the Safety & Efficacy of Endovascular Interventions for the Treatment of SFA Diseasefull<![CDATA[The Utility and Validation of SCAI-CSWG Stages in Patients With Acute Myocardial Infarction-Related Cardiogenic Shock]]>Cindy Grines, MD, MSCAI, Rajesh Rajan, MD, and Mirvat Alasnag, MD, FSCAI, discuss the first study to validate the SCAI-Cardiogenic Shock Working Group stages in a large cohort of AMICS patients in the Gulf region. The findings reveal that higher SCAI stages (D/E) are strongly linked to significantly worse short- and long-term survival outcomes. Patients in advanced stages of shock face more than a threefold higher risk of mortality, underscoring the critical importance of early identification and aggressive treatment to improve survival. Watch the video interview now.Read the article: https://doi.org/10.1016/j.jscai.2024.102461

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/The-Utility-and-Validation-of-SCAI-CSWG-Stages-in-Patients-With-Acute-Myocardial-Infarction-Related-Cardiogenic-Shock-e2vld5a9156b196-2e2d-4374-ba9b-fce202e66023Tue, 21 Jan 2025 14:00:00 GMT<p>Cindy Grines, MD, MSCAI, Rajesh Rajan, MD, and Mirvat Alasnag, MD, FSCAI, discuss the first study to validate the SCAI-Cardiogenic Shock Working Group stages in a large cohort of AMICS patients in the Gulf region. The findings reveal that higher SCAI stages (D/E) are strongly linked to significantly worse short- and long-term survival outcomes. Patients in advanced stages of shock face more than a threefold higher risk of mortality, underscoring the critical importance of early identification and aggressive treatment to improve survival. Watch the video interview now.Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102461" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102461</a></p> no00:14:21The Utility and Validation of SCAI-CSWG Stages in Patients With Acute Myocardial Infarction-Related Cardiogenic Shockfull<![CDATA[Equity in Modifying Plaque of Women with Undertreated Calcified Coronary Artery Disease: Design and Rationale of EMPOWER CAD study]]>The EMPOWER CAD study is a postmarket, prospective, multicenter, single-arm observational study evaluating the Shockwave Coronary IVL system for treating women with calcified coronary artery disease. This conversation features Dean Kereiakes, MD, MSCAI, Margaret McEntegart, MD, FSCAI, Suzanne Baron, MD, FSCAI, & Robert Riley, MD, FSCAI, as they highlight the EMPOWER CAD study and address the underrepresentation of women in interventional cardiology clinical trials. Read the article: https://doi.org/10.1016/j.jscai.2024.102289

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Equity-in-Modifying-Plaque-of-Women-with-Undertreated-Calcified-Coronary-Artery-Disease-Design-and-Rationale-of-EMPOWER-CAD-study-e2t7p8k336e9806-ee93-4309-91bd-02e177ff95c2Thu, 09 Jan 2025 14:00:00 GMT<p>The EMPOWER CAD study is a postmarket, prospective, multicenter, single-arm observational study evaluating the Shockwave Coronary IVL system for treating women with calcified coronary artery disease. This conversation features Dean Kereiakes, MD, MSCAI, Margaret McEntegart, MD, FSCAI, Suzanne Baron, MD, FSCAI, &amp; Robert Riley, MD, FSCAI, as they highlight the EMPOWER CAD study and address the underrepresentation of women in interventional cardiology clinical trials. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102289 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102289 </a></p> no00:27:11Equity in Modifying Plaque of Women with Undertreated Calcified Coronary Artery Disease: Design and Rationale of EMPOWER CAD studyfull<![CDATA[Can Contrast Injections Cause or Propagate Coronary Injuries?]]>The mechanistic association between the hydraulic forces generated during contrast injection and the risk of coronary injury is poorly understood. The authors evaluate whether contrast injections increase intracoronary pressures beyond resting levels and estimate the risk of hydraulic propagation of coronary dissections. Findings suggest that pressure increases are negligible beyond the catheter tip, reducing the likelihood of injuries in distal coronary segments. Dean Kereiakes, MD, MSCAI, Daniel Chamié, and Ricardo Petraco, MD, PhD, discuss the study’s highlights in an accompanying video interview.


Read the article: https://doi.org/10.1016/j.jscai.2024.102396

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Can-Contrast-Injections-Cause-or-Propagate-Coronary-Injuries-e2sj1dpf2b54cbb-e1ba-4bc1-8359-8c66da3aaa50Mon, 23 Dec 2024 14:00:00 GMT<p>The mechanistic association between the hydraulic forces generated during contrast injection and the risk of coronary injury is poorly understood. The authors evaluate whether contrast injections increase intracoronary pressures beyond resting levels and estimate the risk of hydraulic propagation of coronary dissections. Findings suggest that pressure increases are negligible beyond the catheter tip, reducing the likelihood of injuries in distal coronary segments. Dean Kereiakes, MD, MSCAI, Daniel Chamié, and Ricardo Petraco, MD, PhD, discuss the study’s highlights in an accompanying video interview.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102396" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102396</a> </p> no00:17:59Can Contrast Injections Cause or Propagate Coronary Injuries?full<![CDATA[3D Rotational Angiography to Guide Cardiac Catheterization in Critical Infants Below 5kg]]> 3D rotational angiography (3DRA) is a safe and effective tool for guiding cardiac catheterizations in infants with congenital heart disease (CHD) weighing less than 5 kilograms, with no periprocedural deaths or minor adverse events observed and minimal major adverse events. Frank Ing, MD, MSCAI, Chenise N. Lucas, MD, Gregor J. Krings, MD, and Howaida El-Said, MD, FSCAI, discuss the findings, share case examples, and showcase images, emphasizing its ability to reveal critical anatomical details. Read the article: https://doi.org/10.1016/j.jscai.2024.102391

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/3D-Rotational-Angiography-to-Guide-Cardiac-Catheterization-in-Critical-Infants-Below-5kg-e2t699546d9adf0-9fcd-4b93-abbd-2b74b407c1c6Fri, 20 Dec 2024 14:00:00 GMT<p> 3D rotational angiography (3DRA) is a safe and effective tool for guiding cardiac catheterizations in infants with congenital heart disease (CHD) weighing less than 5 kilograms, with no periprocedural deaths or minor adverse events observed and minimal major adverse events. Frank Ing, MD, MSCAI, Chenise N. Lucas, MD, Gregor J. Krings, MD, and Howaida El-Said, MD, FSCAI, discuss the findings, share case examples, and showcase images, emphasizing its ability to reveal critical anatomical details. Read the article:<a href=" https://doi.org/10.1016/j.jscai.2024.102391" rel="noopener noreferrer nofollow" target="_blank"> https://doi.org/10.1016/j.jscai.2024.102391</a></p> no00:36:283D Rotational Angiography to Guide Cardiac Catheterization in Critical Infants Below 5kgfull<![CDATA[The Role of Cardiac Computed Tomography Angiography in Risk Stratification for Coronary Artery Disease]]>Coronary computed tomography angiography (CCTA) enables advanced assessment of atherosclerotic coronary artery disease, including plaque quantification, high-risk feature detection, and pericoronary adipose tissue analysis. This video interview, featuring Sophie E. van Rosendael, MD, PhD, Jonathon Leipsic, MD, Daniel Jones, MD, PhD, and Hamid Mojibian, MD, highlights recent advancements, key evidence, and future directions for comprehensive risk assessment and intervention as described in the comprehensive review published in JSCAI. Read the related article: https://doi.org/10.1016/j.jscai.2024.102230

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/The-Role-of-Cardiac-Computed-Tomography-Angiography-in-Risk-Stratification-for-Coronary-Artery-Disease-e2rukjvc1984fe3-52f9-447a-b2dd-ef576bf25a7bFri, 06 Dec 2024 14:00:00 GMT<p>Coronary computed tomography angiography (CCTA) enables advanced assessment of atherosclerotic coronary artery disease, including plaque quantification, high-risk feature detection, and pericoronary adipose tissue analysis. This video interview, featuring Sophie E. van Rosendael, MD, PhD, Jonathon Leipsic, MD, Daniel Jones, MD, PhD, and Hamid Mojibian, MD, highlights recent advancements, key evidence, and future directions for comprehensive risk assessment and intervention as described in the comprehensive review published in JSCAI. Read the related article: <a href="https://doi.org/10.1016/j.jscai.2024.102230" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102230</a></p> yes00:28:27The Role of Cardiac Computed Tomography Angiography in Risk Stratification for Coronary Artery Diseasefull<![CDATA[Pioneers in IC: Primary PCI for STEMI]]> This installment from SCAI's series, "Pioneers in Interventional Cardiology," features @Tim Henry, MD, MSCAI, @Cindy Grines, MD, MSCAI, and @William O’Neill, MD, MSCAI, who share their journeys, challenges, and the impact that primary PCI for STEMI has had since its birth. Their stories take listeners through the three eras of STEMI care (the thrombolytic era, the facilitated and rescue PCI era, and the primary PCI era) that ultimately led to the adoption of 24-hour Cath labs, while highlighting the challenges and resiliency required to remake the field of interventional cardiology. Read the editorial in JSCAI: https://doi.org/10.1016/j.jscai.2024.102395

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Pioneers-in-IC-Primary-PCI-for-STEMI-e2r7hkfdbf23638-ed5b-4445-8539-11807ea28b9dWed, 20 Nov 2024 14:00:00 GMT<p> This installment from SCAI's series, "Pioneers in Interventional Cardiology," features @Tim Henry, MD, MSCAI, @Cindy Grines, MD, MSCAI, and @William O’Neill, MD, MSCAI, who share their journeys, challenges, and the impact that primary PCI for STEMI has had since its birth. Their stories take listeners through the three eras of STEMI care (the thrombolytic era, the facilitated and rescue PCI era, and the primary PCI era) that ultimately led to the adoption of 24-hour Cath labs, while highlighting the challenges and resiliency required to remake the field of interventional cardiology. Read the editorial in JSCAI: <a href="https://doi.org/10.1016/j.jscai.2024.102395" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102395</a></p> no00:40:36Pioneers in IC: Primary PCI for STEMIfull<![CDATA[Prevalence of CMD & Epicardial Spasm in Patients with Angina & Myocardial Bridge]]>Myocardial bridges are common but not always linked to angina, with unclear mechanisms. The study, published in JSCAI, explores the prevalence of epicardial spasm, microvascular spasm, and endothelium-independent coronary microvascular dysfunction (CMD) in MB patients with chest pain. In this video discussion, Andrew Goldsweig, Tess Allan, John Blair, Samit Shah, and Odayme Quesada provide insights on the findings, which show that these conditions are common in MB patients with chest pain, regardless of the bridge's hemodynamic impact. Read the JSCAI article: https://doi.org/10.1016/j.jscai.2024.102196

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Prevalence-of-CMD--Epicardial-Spasm-in-Patients-with-Angina--Myocardial-Bridge-e2r0746d7396ec4-55a3-4926-804f-cbd752faced2Wed, 06 Nov 2024 14:00:00 GMT<p>Myocardial bridges are common but not always linked to angina, with unclear mechanisms. The study, published in JSCAI, explores the prevalence of epicardial spasm, microvascular spasm, and endothelium-independent coronary microvascular dysfunction (CMD) in MB patients with chest pain. In this video discussion, Andrew Goldsweig, Tess Allan, John Blair, Samit Shah, and Odayme Quesada provide insights on the findings, which show that these conditions are common in MB patients with chest pain, regardless of the bridge's hemodynamic impact. Read the JSCAI article: <a href="https://doi.org/10.1016/j.jscai.2024.102196" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102196</a> </p> no00:28:51Prevalence of CMD & Epicardial Spasm in Patients with Angina & Myocardial Bridgefull<![CDATA[Subaortic Membrane and Cardiac Catheterization—Beware of Diagnostic Pitfall]]>This case study presents a rare cause of subvalvular LVOT obstruction due to a subaortic membrane, highlighting diagnostic challenges in detecting this condition. The video conversation features primary author Jonathan X. Fang, along with panelists Morton Kern, Larry Dean, Gurumurthy Hiremath, and Arnold Seto, who discuss the intricacies of waveform tracing, variations in gradient shape, and potential diagnostic pitfalls in such complex cases. Read the JSCAI article: https://www.jscai.org/article/S2772-9303(24)01728-9/fulltext

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Subaortic-Membrane-and-Cardiac-CatheterizationBeware-of-Diagnostic-Pitfall-e2qbbrcffcb66d1-70b0-4986-9beb-b510d5fba7cbTue, 29 Oct 2024 13:00:00 GMT<p>This case study presents a rare cause of subvalvular LVOT obstruction due to a subaortic membrane, highlighting diagnostic challenges in detecting this condition. The video conversation features primary author Jonathan X. Fang, along with panelists Morton Kern, Larry Dean, Gurumurthy Hiremath, and Arnold Seto, who discuss the intricacies of waveform tracing, variations in gradient shape, and potential diagnostic pitfalls in such complex cases. Read the JSCAI article: <a href="https://www.jscai.org/article/S2772-9303(24)01728-9/fulltext" rel="noopener noreferrer nofollow" target="_blank">https://www.jscai.org/article/S2772-9303(24)01728-9/fulltext</a></p> no00:25:04Subaortic Membrane and Cardiac Catheterization—Beware of Diagnostic Pitfallfull<![CDATA[Blueprint for Building and Sustaining a Cardiogenic Shock Program: Qualitative Survey of 12 US Programs]]>Cardiogenic shock remains a critical challenge, with high mortality rates despite advancements in care. Delayed recognition, late support, and unequal access to care contribute to poor outcomes. Formalized CS programs, modeled after trauma and stroke care, have improved survival but face challenges like staff training, leadership, and funding. This video conversation highlights insights from an article offering practical guidance and tips and tricks for implementing CS programs, featuring discussions with Sandeep Nathan, Raymond Yau, Allison Dupont, and Alexander Truesdell as they share their experiences, challenges, and tips for developing successful CS programs. Read now: https://doi.org/10.1016/j.jscai.2024.102288

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Blueprint-for-Building-and-Sustaining-a-Cardiogenic-Shock-Program-Qualitative-Survey-of-12-US-Programs-e2pq3iv583468e6-356f-4703-9143-205526338634Thu, 17 Oct 2024 13:00:00 GMT<p>Cardiogenic shock remains a critical challenge, with high mortality rates despite advancements in care. Delayed recognition, late support, and unequal access to care contribute to poor outcomes. Formalized CS programs, modeled after trauma and stroke care, have improved survival but face challenges like staff training, leadership, and funding. This video conversation highlights insights from an article offering practical guidance and tips and tricks for implementing CS programs, featuring discussions with Sandeep Nathan, Raymond Yau, Allison Dupont, and Alexander Truesdell as they share their experiences, challenges, and tips for developing successful CS programs. Read now: <a href="https://doi.org/10.1016/j.jscai.2024.102288" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102288</a></p> no00:21:44Blueprint for Building and Sustaining a Cardiogenic Shock Program: Qualitative Survey of 12 US Programsfull<![CDATA[SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCI]]> ST-elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality in the United States. Timely reperfusion with primary percutaneous coronary intervention is associated with improved outcomes. SCAI puts forth an expert consensus document regarding best practices for cardiac catheterization laboratory team readiness, arterial access with an algorithm to help determine proper arterial access in STEMI, and diagnostic angiography. This consensus statement highlights the strengths and limitations of various diagnostic and therapeutic interventions to access and treat a patient with STEMI in the cath lab, reviews different options to manage large thrombus burden during STEMI and reviews the management of STEMI across the spectrum of various anatomical and clinical circumstances. This conversation discussing this article features Cindy Grines, MD, MSCAI, Sandeep Nathan, MD, MSc, FSCAI, Jacqueline Tamis-Holland, MD, FSCAI, and Sanjit Jolly, MD, MSc, FSCAI. Read the article: https://doi.org/10.1016/j.jscai.2024.102294

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-the-Management-of-Patients-With-STEMI-Referred-for-Primary-PCI-e2uhh4mc78d6b11-8495-4b7f-81c7-505f67511ffcMon, 07 Oct 2024 13:00:00 GMT<p> ST-elevation myocardial infarction (STEMI) remains a leading cause of morbidity and mortality in the United States. Timely reperfusion with primary percutaneous coronary intervention is associated with improved outcomes. SCAI puts forth an expert consensus document regarding best practices for cardiac catheterization laboratory team readiness, arterial access with an algorithm to help determine proper arterial access in STEMI, and diagnostic angiography. This consensus statement highlights the strengths and limitations of various diagnostic and therapeutic interventions to access and treat a patient with STEMI in the cath lab, reviews different options to manage large thrombus burden during STEMI and reviews the management of STEMI across the spectrum of various anatomical and clinical circumstances. This conversation discussing this article features Cindy Grines, MD, MSCAI, Sandeep Nathan, MD, MSc, FSCAI, Jacqueline Tamis-Holland, MD, FSCAI, and Sanjit Jolly, MD, MSc, FSCAI. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102294" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102294</a> </p> no00:25:05SCAI Expert Consensus Statement on the Management of Patients With STEMI Referred for Primary PCIfull<![CDATA[Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT Study]]> This study assessed the relationships of patient, lesion, and procedural characteristics to the subsequent risk of major and minor adverse limb events over the decade after successful endovascular revascularization of the superficial femoral artery for chronic limb-threatening ischemia (CLTI) or lifestyle-limiting claudication. Drs. Sahil Parikh, Scott Kinley, Marc Bonaca, & Kevin Rogers discuss the highlights and results. Read the article: https://doi.org/10.1016/j.jscai.2024.102241

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Long-Term-Adverse-Limb-Events-After-Femoral-Artery-Endovascular-Revascularization-The-Boston-FAROUT-Study-e2t1ku049f3483e-15a7-425f-b009-949a2df21785Fri, 04 Oct 2024 13:00:00 GMT<p> This study assessed the relationships of patient, lesion, and procedural characteristics to the subsequent risk of major and minor adverse limb events over the decade after successful endovascular revascularization of the superficial femoral artery for chronic limb-threatening ischemia (CLTI) or lifestyle-limiting claudication. Drs. Sahil Parikh, Scott Kinley, Marc Bonaca, &amp; Kevin Rogers discuss the highlights and results. Read the article: <a href=" https://doi.org/10.1016/j.jscai.2024.102241" rel="noopener noreferrer nofollow" target="_blank"> https://doi.org/10.1016/j.jscai.2024.102241</a></p> no00:19:00Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT Studyfull<![CDATA[Outcomes of Saphenous Vein Graft PCI Using Contemporary Drug-Eluting Stents: A SCAAR Report]]> The authors investigated clinical outcomes of Saphenous Vein Graft-PCI using contemporary drug-eluting stents. Conclusions: patients who underwent SVG-PCI with contemporary DES, patients were characterized by a high-risk profile and high rates of adverse clinical events. However, the incidence of stent and lesion-related events was low. Expert leaders, Sandeep Nathan, Saman Saidi-Seresht, Stefan James, Timir Paul discuss the results on "Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report." Read the manuscript: https://doi.org/10.1016/j.jscai.2024.102232

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Outcomes-of-Saphenous-Vein-Graft-PCI-Using-Contemporary-Drug-Eluting-Stents-A-SCAAR-Report-e2p2ld609f7308d-2c0d-4d99-8094-0fff52f00c69Thu, 26 Sep 2024 13:00:00 GMT<p> The authors investigated clinical outcomes of Saphenous Vein Graft-PCI using contemporary drug-eluting stents. Conclusions: patients who underwent SVG-PCI with contemporary DES, patients were characterized by a high-risk profile and high rates of adverse clinical events. However, the incidence of stent and lesion-related events was low. Expert leaders, Sandeep Nathan, Saman Saidi-Seresht, Stefan James, Timir Paul discuss the results on "Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report." Read the manuscript: <a href="https://doi.org/10.1016/j.jscai.2024.102232" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102232</a></p> no00:21:16Outcomes of Saphenous Vein Graft PCI Using Contemporary Drug-Eluting Stents: A SCAAR Reportfull<![CDATA[Radiation Exposure and Protection for (Assumed) Pregnant Interventional Cardiologists and Electrophysiologists]]>Concerns about fetal radiation exposure may deter women from pursuing careers in invasive cardiology. However, real-world data on fetal exposure is limited. This study aimed to measure radiation exposure to invasive cardiologists that could affect the fetus during pregnancy. Leaders—David G. Rizik, Kenneth A. Fetterly, Mayra Guerrero, Celina Yong, and Holly Bauser-Heaton—discuss the findings. Watch the video to explore key highlights. Read the article: https://doi.org/10.1016/j.jscai.2024.102239

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Radiation-Exposure-and-Protection-for-Assumed-Pregnant-Interventional-Cardiologists-and-Electrophysiologists-e2op13r7b93a2d2-fe82-4be9-b5b9-81120955f34eMon, 23 Sep 2024 18:05:54 GMT<p>Concerns about fetal radiation exposure may deter women from pursuing careers in invasive cardiology. However, real-world data on fetal exposure is limited. This study aimed to measure radiation exposure to invasive cardiologists that could affect the fetus during pregnancy. Leaders—David G. Rizik, Kenneth A. Fetterly, Mayra Guerrero, Celina Yong, and Holly Bauser-Heaton—discuss the findings. Watch the video to explore key highlights. Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.102239" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102239</a></p> no00:22:37Radiation Exposure and Protection for (Assumed) Pregnant Interventional Cardiologists and Electrophysiologistsfull<![CDATA[Pioneers in IC: The Emory-Gruentzig Days]]>This series from SCAI, "Pioneers in Interventional Cardiology," features Spencer B. King III, MD, MSCAI, John S. Douglas, Jr., MD, MSCAI, H. Vernon "Skip" Anderson, MD, FSCAI, and J. Jeffrey Marshall, MD, MSCAI. The panel discusses the groundbreaking work of Andreas Gruentzig, MD, and shares their personal recollections, memories, and firsthand experiences. This interview discusses the significance of Dr. Gruentzig’s contributions and highlights pivotal moments in the history of interventional cardiology. SCAI honors the memory of Dr. Andreas Gruentzig and his tireless efforts to advance the field of interventional cardiology.


Read the editorial: https://doi.org/10.1016/j.jscai.2024.102154

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Pioneers-in-IC-The-Emory-Gruentzig-Days-e2mvrakf2f7a60b-0c14-46ff-8c0a-29f0f87b2a46Wed, 31 Jul 2024 13:00:00 GMT<p>This series from SCAI, "Pioneers in Interventional Cardiology," features Spencer B. King III, MD, MSCAI, John S. Douglas, Jr., MD, MSCAI, H. Vernon "Skip" Anderson, MD, FSCAI, and J. Jeffrey Marshall, MD, MSCAI. The panel discusses the groundbreaking work of Andreas Gruentzig, MD, and shares their personal recollections, memories, and firsthand experiences. This interview discusses the significance of Dr. Gruentzig’s contributions and highlights pivotal moments in the history of interventional cardiology. SCAI honors the memory of Dr. Andreas Gruentzig and his tireless efforts to advance the field of interventional cardiology.</p> <p><br /></p> <p>Read the editorial: <a href="https://doi.org/10.1016/j.jscai.2024.102154" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.102154</a></p> no00:47:46Pioneers in IC: The Emory-Gruentzig Daysfull<![CDATA[Outcomes from MT for DVT: Insights from the PINC AI Healthcare Database]]>Drs. Sahil Parikh, Derek Mittleider, and Matthew Finn discuss "Outcomes from Mechanical Thrombectomy for Deep Vein Thrombosis: Insights from the PINC AI Healthcare Database" published in JSCAI.

Read the article:

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Outcomes-from-MT-for-DVT-Insights-from-the-PINC-AI-Healthcare-Database-e2mdphe4cd88687-4729-4e68-b3ff-8bd3ce821d6aThu, 25 Jul 2024 11:05:00 GMT<p>Drs. Sahil Parikh, Derek Mittleider, and Matthew Finn discuss "Outcomes from Mechanical Thrombectomy for Deep Vein Thrombosis: Insights from the PINC AI Healthcare Database" published in JSCAI. </p> <p>Read the article: </p> no00:23:45Outcomes from MT for DVT: Insights from the PINC AI Healthcare Databasefull<![CDATA[Stretching to Reduce Pain-Related Disability Among Echocardiographic and Interventional Laboratory Employees—A Pilot Study]]> Drs. Russell Gelfman, Mandeep Singh, Nishtha Sareen, Allison Dupont, & Poonam Velagapudi discuss the article in JSCAI titled: "Stretching to Reduce Pain-Related Disability Among Echocardiographic and Interventional Laboratory Employees—A Pilot Study"


Read the article: https://doi.org/10.1016/j.jscai.2024.101353

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Stretching-to-Reduce-Pain-Related-Disability-Among-Echocardiographic-and-Interventional-Laboratory-EmployeesA-Pilot-Study-e2l478fcd1e8a8b-745b-47ec-9605-34d00e2c5ec9Tue, 07 May 2024 13:00:00 GMT<p> Drs. Russell Gelfman, Mandeep Singh, Nishtha Sareen, Allison Dupont, &amp; Poonam Velagapudi discuss the article in JSCAI titled: "Stretching to Reduce Pain-Related Disability Among Echocardiographic and Interventional Laboratory Employees—A Pilot Study"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101353" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101353</a></p> no00:26:39Stretching to Reduce Pain-Related Disability Among Echocardiographic and Interventional Laboratory Employees—A Pilot Studyfull<![CDATA[Temporal Trends in TAVR for Isolated Severe Aortic Stenosis]]>Drs. Suzanne Baron, Tanush Gupta, Michael Dauerman, & Micheal Reardon discuss trends in TAVR, hypothesizing its growth among younger patients with isolated severe AS.


Read the article: https://doi.org/10.1016/j.jscai.2024.101861

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Temporal-Trends-in-TAVR-for-Isolated-Severe-Aortic-Stenosis-e2l47pn8ab73f04-5267-40ab-a467-6c5d079bcd2aFri, 05 Apr 2024 13:00:00 GMT<p>Drs. Suzanne Baron, Tanush Gupta, Michael Dauerman, &amp; Micheal Reardon discuss trends in TAVR, hypothesizing its growth among younger patients with isolated severe AS.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101861" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101861</a></p> no00:19:08Temporal Trends in TAVR for Isolated Severe Aortic Stenosisfull<![CDATA[Are There Disparities in the Utilization of the Impella Device in Acute Myocardial Infarction and Cardiogenic Shock in the United States?]]> Drs. Zaid Almarzooq, Mauricio Cohen, Robert Yeh, and Sandeep Nathan discuss the article in JSCAI titled: "Are There Disparities in the Utilization of the Impella Device in Acute Myocardial Infarction and Cardiogenic Shock in the United States?"


Read the article: https://doi.org/10.1016/j.jscai.2024.101336

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Are-There-Disparities-in-the-Utilization-of-the-Impella-Device-in-Acute-Myocardial-Infarction-and-Cardiogenic-Shock-in-the-United-States-e2l45l54c546e3b-2491-484f-90c8-6f9448306364Tue, 02 Apr 2024 13:00:00 GMT<p> Drs. Zaid Almarzooq, Mauricio Cohen, Robert Yeh, and Sandeep Nathan discuss the article in JSCAI titled: "Are There Disparities in the Utilization of the Impella Device in Acute Myocardial Infarction and Cardiogenic Shock in the United States?"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101336" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101336</a></p> no00:18:32Are There Disparities in the Utilization of the Impella Device in Acute Myocardial Infarction and Cardiogenic Shock in the United States?full<![CDATA[The Role of CTA in Severe Aortic Stenosis]]>Drs. Jonathon Leipsic, Tej Sheth, and Abdul Ihdayhid discuss the role of CTA in severe AS, highlighting two papers from JSCAI.


1- Gated Computed Tomography Evaluation of the Aortic Root for Treatment Planning of Patients With Aortic Stenosis.

Read the article: https://doi.org/10.1016/j.jscai.2024.101298


2-Feasibility and Utility of Anatomical and Physiological Evaluation of Coronary Disease With Cardiac CT in Severe Aortic Stenosis (FUTURE-AS Registry): Rationale and Design.

Read the article: https://doi.org/10.1016/j.jscai.2023.101293

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/The-Role-of-CTA-in-Severe-Aortic-Stenosis-e2l46ifdce5305d-582b-422a-aec2-7a27bcb1caabTue, 26 Mar 2024 13:00:00 GMT<p>Drs. Jonathon Leipsic, Tej Sheth, and Abdul Ihdayhid discuss the role of CTA in severe AS, highlighting two papers from JSCAI.</p> <p><br /></p> <p>1- Gated Computed Tomography Evaluation of the Aortic Root for Treatment Planning of Patients With Aortic Stenosis.</p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101298" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101298</a></p> <p><br /></p> <p>2-Feasibility and Utility of Anatomical and Physiological Evaluation of Coronary Disease With Cardiac CT in Severe Aortic Stenosis (FUTURE-AS Registry): Rationale and Design.</p> <p>Read the article:<a href="https://doi.org/10.1016/j.jscai.2023.101293 " rel="noopener noreferrer nofollow" target="_blank"> https://doi.org/10.1016/j.jscai.2023.101293 </a></p> no00:26:58The Role of CTA in Severe Aortic Stenosisfull<![CDATA[Plaque Characterization in CAD using CTA]]>Drs. Jonathon A. Leipsic, Bon-Kwon Koo, Sarah Rinehart, Christos Bourantas, and Daniel Chamié discuss three key articles:

1- Non-Invasive Coronary Physiological Assessment Derived from Computed Tomography.

Read the article: https://doi.org/10.1016/j.jscai.2024.101304

2- Efficacy of Coronary Calcium Score in Predicting Coronary Artery Morphology in Patients With Obstructive Coronary Artery Disease.

Read the article: https://doi.org/10.1016/j.jscai.2024.101308

3- Utility of AI Plaque Quantification: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated With Quantified Plaque Analysis (DECODE) Study.

Read the article: https://doi.org/10.1016/j.jscai.2024.101296

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Plaque-Characterization-in-CAD-using-CTA-e2l46bk2da66761-da27-4368-bf61-a7f78fdf8853Tue, 26 Mar 2024 13:00:00 GMT<p>Drs. Jonathon A. Leipsic, Bon-Kwon Koo, Sarah Rinehart, Christos Bourantas, and Daniel Chamié discuss three key articles: </p> <p>1- Non-Invasive Coronary Physiological Assessment Derived from Computed Tomography.</p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101304" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101304</a></p> <p>2- Efficacy of Coronary Calcium Score in Predicting Coronary Artery Morphology in Patients With Obstructive Coronary Artery Disease.</p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101308" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101308</a></p> <p>3- Utility of AI Plaque Quantification: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated With Quantified Plaque Analysis (DECODE) Study. </p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101296" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101296</a></p> no00:32:32Plaque Characterization in CAD using CTAfull<![CDATA[CTA for PCI Planning]]>Drs. Natalia Pinilla-Echeverri, Carlos Collet, Jeffrey Schussler, and Daniel Jones discuss two articles in JSCAI:

1- Advanced CT Imaging for the Assessment of Calcific Coronary Artery Disease and PCI Planning

Read the article: https://doi.org/10.1016/j.jscai.2024.101299


2- Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective.

Read the article: https://doi.org/10.1016/j.jscai.2024.101301

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/CTA-for-PCI-Planning-e2l4616b4318283-4520-4ef2-b2af-eb9615cb96daTue, 26 Mar 2024 13:00:00 GMT<p>Drs. Natalia Pinilla-Echeverri, Carlos Collet, Jeffrey Schussler, and Daniel Jones discuss two articles in JSCAI: </p> <p>1- Advanced CT Imaging for the Assessment of Calcific Coronary Artery Disease and PCI Planning</p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101299" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101299</a></p> <p><br /></p> <p>2- Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective. </p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101301" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101301</a></p> no00:20:57CTA for PCI Planningfull<![CDATA[Current Understanding and Future Directions of Transcatheter Devices to Assist Failing Fontan]]>Drs. Frank Ing, Vivian Dimas, and Athar Qureshi discuss the JSCAI article titled:


Read the article: https://doi.org/10.1016/j.jscai.2024.101334

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Current-Understanding-and-Future-Directions-of-Transcatheter-Devices-to-Assist-Failing-Fontan-e2l46srbe51b658-72b9-444a-8865-bd2f8b901c5dTue, 12 Mar 2024 13:00:00 GMT<p>Drs. Frank Ing, Vivian Dimas, and Athar Qureshi discuss the JSCAI article titled: </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101334 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101334 </a></p> no00:24:42Current Understanding and Future Directions of Transcatheter Devices to Assist Failing Fontanfull<![CDATA[First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System]]>Drs. Ziad Ali, James Muller, David Rizik, and Tom Johnson discuss the First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System.


Read the article: https://doi.org/10.1016/j.jscai.2024.101344

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/First-in-Human-Experience-With-a-Novel-Multimodality-DeepOCT-NIRS-Intracoronary-Imaging-System-e2l45pl0bf615d7-9214-48fe-9ca7-de0cb0acb8b7Tue, 05 Mar 2024 14:00:00 GMT<p>Drs. Ziad Ali, James Muller, David Rizik, and Tom Johnson discuss the First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging System.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2024.101344" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2024.101344</a></p> no00:26:07First-in-Human Experience With a Novel Multimodality DeepOCT-NIRS Intracoronary Imaging Systemfull<![CDATA[SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions]]>Drs. Alexandra Lansky, Binita Shah, Robert Riley, & Daniel Chamie discuss the SCAI statement on the Management of Calcified Coronary Lesions.


Read the article: https://doi.org/10.1016/j.jscai.2023.101259

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-the-Management-of-Calcified-Coronary-Lesions-e2l442ob839852e-89e6-4c36-9bd2-02a6a0686cc0Wed, 31 Jan 2024 14:00:00 GMT<p>Drs. Alexandra Lansky, Binita Shah, Robert Riley, &amp; Daniel Chamie discuss the SCAI statement on the Management of Calcified Coronary Lesions.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101259" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101259</a></p> no00:25:39SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesionsfull<![CDATA[Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsy]]>Drs. Neel Butala, Jennifer Rymer, Margaret McEntegart, Dean Kereiakes, & Robert Yeh as they discuss the trends and hospital variation in calcium modification and IVL use.


Read the artice: https://doi.org/10.1016/j.jscai.2023.101254

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Use-of-Calcium-Modification-During-Percutaneous-Coronary-Intervention-After-Introduction-of-Coronary-Intravascular-Lithotripsy-e2l8rdv31b87d98-b8fb-4cd3-805f-eb332175b245Mon, 22 Jan 2024 14:00:00 GMT<p>Drs. Neel Butala, Jennifer Rymer, Margaret McEntegart, Dean Kereiakes, &amp; Robert Yeh as they discuss the trends and hospital variation in calcium modification and IVL use. </p> <p><br /></p> <p>Read the artice: <a href="https://doi.org/10.1016/j.jscai.2023.101254" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101254</a></p> no00:28:11Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsyfull<![CDATA[IVUS in PAD and Deep Venous Interventions: Multidisciplinary Expert Opinion]]>How can IVUS improve patient outcomes? Drs. Eric Secemsky, Christopher Kwolek, Kush Desai, and Sahil Parikh discuss the current state of lower extremity revascularization, training, and competency, and how to leverage IVUS to optimize patient care.


Read the article: https://doi.org/10.1016/j.jscai.2023.101205

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/IVUS-in-PAD-and-Deep-Venous-Interventions-Multidisciplinary-Expert-Opinion-e2l4357ef04e6bc-6f12-422e-a7ef-c0ab2616021dTue, 09 Jan 2024 14:00:00 GMT<p>How can IVUS improve patient outcomes? Drs. Eric Secemsky, Christopher Kwolek, Kush Desai, and Sahil Parikh discuss the current state of lower extremity revascularization, training, and competency, and how to leverage IVUS to optimize patient care. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101205 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101205 </a></p> no00:17:16IVUS in PAD and Deep Venous Interventions: Multidisciplinary Expert Opinionfull<![CDATA[PICS Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Disease]]>Drs. Ralf Holzer, Frank Ing, Aimee Armstrong, Shakeel Qureshi, & Mohammad Alnoor discuss the best practice recommendations from the Cardiac Catheterization for Peds Pts & Adults with ACHD.


Read the article: https://doi.org/10.1016/j.jscai.2023.101181

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/PICS-Expert-Consensus-Statement-on-Cardiac-Catheterization-for-Pediatric-Patients-and-Adults-With-Congenital-Heart-Disease-e2l439b310e2e79-8a80-48b3-a765-315522ebf164Fri, 15 Dec 2023 14:00:00 GMT<p>Drs. Ralf Holzer, Frank Ing, Aimee Armstrong, Shakeel Qureshi, &amp; Mohammad Alnoor discuss the best practice recommendations from the Cardiac Catheterization for Peds Pts &amp; Adults with ACHD.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101181" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101181</a></p> no00:24:37PICS Expert Consensus Statement on Cardiac Catheterization for Pediatric Patients and Adults With Congenital Heart Diseasefull<![CDATA[Heart Failure and Secondary Mitral Regurgitation: A Contemporary Review]]>Drs. Gregg Stone, Linda Gilliam, Philippe Généreux, and Amit Vora discuss the article in JSCAI, "Heart Failure and Secondary Mitral Regurgitation: A Contemporary Review"


Read the article: https://doi.org/10.1016/j.jscai.2023.101195

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Heart-Failure-and-Secondary-Mitral-Regurgitation-A-Contemporary-Review-e2l2ptd8a98ecc7-2e97-4b89-bcac-182a583cf701Mon, 04 Dec 2023 14:00:00 GMT<p>Drs. Gregg Stone, Linda Gilliam, Philippe Généreux, and Amit Vora discuss the article in JSCAI, "Heart Failure and Secondary Mitral Regurgitation: A Contemporary Review"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101195" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101195</a></p> no00:31:34Heart Failure and Secondary Mitral Regurgitation: A Contemporary Reviewfull<![CDATA[National Trends for Temporary Mechanical Circulatory Support Utilization in Patients With Cardiogenic Shock From Decompensated Chronic Heart Failure: Incidence, Predictors, Outcomes, and Cost]]>Drs Supriya Shore, Alexander Truesdell, Babar Basir, and Sandeep Nathan discuss the trends in tMCS use, associated outcomes, and hospitalization costs in HF-CS.


Read the article: https://doi.org/10.1016/j.jscai.2023.101177

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/National-Trends-for-Temporary-Mechanical-Circulatory-Support-Utilization-in-Patients-With-Cardiogenic-Shock-From-Decompensated-Chronic-Heart-Failure-Incidence--Predictors--Outcomes--and-Cost-e2l40hpf1c7eb9f-ef69-41a8-91a0-64f5ee6dd7dbMon, 04 Dec 2023 14:00:00 GMT<p>Drs Supriya Shore, Alexander Truesdell, Babar Basir, and Sandeep Nathan discuss the trends in tMCS use, associated outcomes, and hospitalization costs in HF-CS.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101177" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101177</a></p> no00:20:04National Trends for Temporary Mechanical Circulatory Support Utilization in Patients With Cardiogenic Shock From Decompensated Chronic Heart Failure: Incidence, Predictors, Outcomes, and Costfull<![CDATA[Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscape]]>Drs. David Rizik, Michael Brener, Mark Reisman, & Daniel Burkhof discuss the article in JSCAI titled: "Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscape"


Read the article: https://doi.org/10.1016/j.jscai.2023.101196

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Reverse-Left-Ventricular-Remodeling-With-Transcatheter-Interventions-in-Chronic-Heart-Failure-Syndromes-An-Updated-Appraisal-of-the-Device-Landscape-e2l40n861e40f9a-fec8-44d9-8ca4-799b9010aba3Mon, 04 Dec 2023 14:00:00 GMT<p>Drs. David Rizik, Michael Brener, Mark Reisman, &amp; Daniel Burkhof discuss the article in JSCAI titled: "Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscape"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101196" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101196</a></p> no00:28:55Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscapefull<![CDATA[Hemodynamic Monitoring Devices in the Management of Outpatient Heart Failure]]>Drs. Scott Lundgren, Jeffrey Testani, and William T. Abraham discuss the article in JSCAI on "Hemodynamic Monitoring Devices in the Management of Outpatient Heart Failure"


Read the article: https://doi.org/10.1016/j.jscai.2023.101186

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Hemodynamic-Monitoring-Devices-in-the-Management-of-Outpatient-Heart-Failure-e2l403i0be30242-8d79-4c64-bb6a-2a5cf32e4083Mon, 04 Dec 2023 14:00:00 GMT<p>Drs. Scott Lundgren, Jeffrey Testani, and William T. Abraham discuss the article in JSCAI on "Hemodynamic Monitoring Devices in the Management of Outpatient Heart Failure"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101186" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101186</a></p> no00:24:31Hemodynamic Monitoring Devices in the Management of Outpatient Heart Failurefull<![CDATA[Atrial Shunt Therapy for Heart Failure: An Update]]>Drs. Suzanne Baron, Vikrant Jagadeesan, William Gray, & Sanjiv Shah discuss atrial shunt therapeutics, covering current HF treatment, atrial shunt development history, various devices and procedures, unanswered questions, and future considerations.


Read the article: https://doi.org/10.1016/j.jscai.2023.101203

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Atrial-Shunt-Therapy-for-Heart-Failure-An-Update-e2l43o65edeaf24-f3af-4a4e-98bd-d1cad5ada47dMon, 04 Dec 2023 14:00:00 GMT<p>Drs. Suzanne Baron, Vikrant Jagadeesan, William Gray, &amp; Sanjiv Shah discuss atrial shunt therapeutics, covering current HF treatment, atrial shunt development history, various devices and procedures, unanswered questions, and future considerations.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101203" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101203</a></p> no00:32:13Atrial Shunt Therapy for Heart Failure: An Updatefull<![CDATA[Cardiac Contractility Modulation for Heart Failure: Current and Future Directions]]>Drs. Philippe Généreux, Daniel Pipilas, & Theofanie Mela discuss the article in JSCAI "Cardiac Contractility Modulation for Heart Failure: Current and Future Directions"


Read the article: https://doi.org/10.1016/j.jscai.2023.101176

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Cardiac-Contractility-Modulation-for-Heart-Failure-Current-and-Future-Directions-e2l401i999e3307-5307-4c9e-b91d-d820af37ff47Mon, 04 Dec 2023 14:00:00 GMT<p>Drs. Philippe Généreux, Daniel Pipilas, &amp; Theofanie Mela discuss the article in JSCAI "Cardiac Contractility Modulation for Heart Failure: Current and Future Directions"</p> <p><br /></p> <p>Read the article: https://doi.org/10.1016/j.jscai.2023.101176</p> no00:16:04Cardiac Contractility Modulation for Heart Failure: Current and Future Directionsfull<![CDATA[Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry]]>Drs. Sahil Parikh, James Horowitz, & Sameer Khandar discuss article in JSCAI on "Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry"


Read the article: https://doi.org/10.1016/j.jscai.2023.101124

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Mechanical-Thrombectomy-for-High-Risk-Pulmonary-Embolism-Insights-From-the-US-Cohort-of-the-FLASH-Registry-e2l40kn40ae9280-3801-4c11-95fc-50f83dc50782Tue, 31 Oct 2023 13:00:00 GMT<p>Drs. Sahil Parikh, James Horowitz, &amp; Sameer Khandar discuss article in JSCAI on "Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101124" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101124</a></p> no00:21:29Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registryfull<![CDATA[Novel Lithotripsy-Assisted Transcatheter Aortic Valve Replacement May Reduce Risk of Aortic Root Rupture]]>Drs. David Rizik, Puvi Seshiah, Dean Kereiakes, and Suzanne Baron discuss a new technique for delivering lithotripsy therapy prior to TAVR.

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Novel-Lithotripsy-Assisted-Transcatheter-Aortic-Valve-Replacement-May-Reduce-Risk-of-Aortic-Root-Rupture-e2l2nr6bd6884b6-ebc1-4e66-bb39-a28fd2d9f3deTue, 24 Oct 2023 13:00:00 GMT<p>Drs. David Rizik, Puvi Seshiah, Dean Kereiakes, and Suzanne Baron discuss a new technique for delivering lithotripsy therapy prior to TAVR.</p> no00:29:12Novel Lithotripsy-Assisted Transcatheter Aortic Valve Replacement May Reduce Risk of Aortic Root Rupturefull<![CDATA[Early Clinical Outcomes of Patients With Stress-Induced Cardiomyopathy Receiving Acute Mechanical Support in the US]]>Drs. Carlos Davila, Cindy Grines, and Bill O'Neill discuss the article "Early Clinical Outcomes of Patients With Stress-Induced Cardiomyopathy Receiving Acute Mechanical Support in the US" in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2023.101185

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Early-Clinical-Outcomes-of-Patients-With-Stress-Induced-Cardiomyopathy-Receiving-Acute-Mechanical-Support-in-the-US-e2l2pia0aa1e1c5-b9b8-491e-9522-f993baa7fb04Mon, 09 Oct 2023 13:00:00 GMT<p>Drs. Carlos Davila, Cindy Grines, and Bill O'Neill discuss the article "Early Clinical Outcomes of Patients With Stress-Induced Cardiomyopathy Receiving Acute Mechanical Support in the US" in JSCAI. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101185" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101185</a></p> no00:22:56Early Clinical Outcomes of Patients With Stress-Induced Cardiomyopathy Receiving Acute Mechanical Support in the USfull<![CDATA[Impact of Stenting on PDA Length, Curvature, and Pulsatile Deformations Based on CT Assessment]]>Drs. Frank Ing, Howaida El-Said, David Nykanen and Ziyad Hijazi discuss the article in JSCAI "Impact of Stenting on PDA Length, Curvature, and Pulsatile Deformations Based on CT Assessment"


Read the article: https://doi.org/10.1016/j.jscai.2023.101134

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Impact-of-Stenting-on-PDA-Length--Curvature--and-Pulsatile-Deformations-Based-on-CT-Assessment-e2l2p40f24aa1eb-aba2-4165-bbeb-4f11510ffd8bFri, 15 Sep 2023 13:00:00 GMT<p>Drs. Frank Ing, Howaida El-Said, David Nykanen and Ziyad Hijazi discuss the article in JSCAI "Impact of Stenting on PDA Length, Curvature, and Pulsatile Deformations Based on CT Assessment"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101134" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101134</a></p> no00:25:47Impact of Stenting on PDA Length, Curvature, and Pulsatile Deformations Based on CT Assessmentfull<![CDATA[Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits and Bioprosthetic Valves]]>Drs. Kelly Han, Frank Ing, Matthew Gillespie, and Shabana Shahanavaz, discuss the key takeaways from the recently published White Paper on Technical Recommendations for CT Guidance in the Right Ventricular Outflow Tract by Society of Cardiovascular Computed Tomography (SCCT), Congenital Heart Surgeons’ Society (CHSS), and Society for Cardiovascular Angiography & Interventions (SCAI)


Read the paper: https://doi.org/10.1016/j.jscai.2023.101117

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Technical-Recommendations-for-Computed-Tomography-Guidance-of-Intervention-in-the-Right-Ventricular-Outflow-Tract-Native-RVOT--Conduits-and-Bioprosthetic-Valves-e2l1q7k041b9493-b571-44b0-b4af-dcd27b74a96aTue, 29 Aug 2023 13:00:00 GMT<p>Drs. Kelly Han, Frank Ing, Matthew Gillespie, and Shabana Shahanavaz, discuss the key takeaways from the recently published White Paper on Technical Recommendations for CT Guidance in the Right Ventricular Outflow Tract by Society of Cardiovascular Computed Tomography (SCCT), Congenital Heart Surgeons’ Society (CHSS), and Society for Cardiovascular Angiography &amp; Interventions (SCAI)</p> <p><br /></p> <p>Read the paper: <a href="https://doi.org/10.1016/j.jscai.2023.101117" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101117</a> </p> no00:29:01Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits and Bioprosthetic Valvesfull<![CDATA[SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations]]>Drs. Andrew Goldsweig, Rajesh V. Swaminathan, Herb Aronow, Debbie Cohen, Taisei Kobayashi, Eric A. Secemsky, and David E. Kandzari discuss the article in JSCAI "SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations"


Read the article: https://doi.org/10.1016/j.jscai.2023.101121

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Position-Statement-on-Renal-Denervation-for-Hypertension-Patient-Selection--Operator-Competence--Training-and-Techniques--and-Organizational-Recommendations-e2l2oe1bec66aa6-6b30-4a73-b8c3-7194ce0b60a9Mon, 21 Aug 2023 13:00:00 GMT<p>Drs. Andrew Goldsweig, Rajesh V. Swaminathan, Herb Aronow, Debbie Cohen, Taisei Kobayashi, Eric A. Secemsky, and David E. Kandzari discuss the article in JSCAI "SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101121 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101121 </a></p> no00:30:19SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendationsfull<![CDATA[Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1 &Part 2]]>Drs. Philippe Genereux, David Baran, Daniel Burkhoff, and Andrew Goldsweig discuss a two-part series on acute decompensated heart failure.


Read the articles:

Part 1- https://doi.org/10.1016/j.jscai.2023.101060

Part 2- https://doi.org/10.1016/j.jscai.2023.101059

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Patient-Selection-and-End-Point-Definitions-for-Decongestion-Studies-in-Acute-Decompensated-Heart-Failure-Part-1-Part-2-e2l180bdad19ca2-bd4a-40fb-bebd-ee7fe01f2620Tue, 08 Aug 2023 13:00:00 GMT<p>Drs. Philippe Genereux, David Baran, Daniel Burkhoff, and Andrew Goldsweig discuss a two-part series on acute decompensated heart failure. </p> <p><br /></p> <p>Read the articles:</p> <p>Part 1- <a href="https://doi.org/10.1016/j.jscai.2023.101060" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101060</a></p> <p>Part 2- <a href="https://doi.org/10.1016/j.jscai.2023.101059" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101059</a></p> no00:30:03Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1 &Part 2full<![CDATA[Advocacy 101 for Interventional Cardiologists: A Society for Cardiovascular Angiography & Interventions Policy Statement]]>Drs. Andrew Goldsweig, Lyndon Box, Deepali Tukaye, and Jeff Marshall discuss the article in JSCAI "Advocacy 101 for Interventional Cardiologists: A Society for Cardiovascular Angiography & Interventions Policy Statement"


Read the article: https://doi.org/10.1016/j.jscai.2023.101048

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Advocacy-101-for-Interventional-Cardiologists-A-Society-for-Cardiovascular-Angiography--Interventions-Policy-Statement-e2l17tk57943ec0-e2b6-434c-82ee-4cca65a0bfceSat, 29 Jul 2023 13:00:00 GMT<p>Drs. Andrew Goldsweig, Lyndon Box, Deepali Tukaye, and Jeff Marshall discuss the article in JSCAI "Advocacy 101 for Interventional Cardiologists: A Society for Cardiovascular Angiography &amp; Interventions Policy Statement"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101048" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101048</a></p> no00:22:59Advocacy 101 for Interventional Cardiologists: A Society for Cardiovascular Angiography & Interventions Policy Statementfull<![CDATA[Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options]]>Drs. Sandeep Nathan, Alessandra Sala, and Rebecca Hahn discuss the article in JSCAI, "Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options"


Read the article: https://doi.org/10.1016/j.jscai.2023.101041

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Tricuspid-Valve-Regurgitation-Current-Understanding-and-Novel-Treatment-Options-e2l1q1ad92431b3-d36d-4ae9-94ab-3cfe8d3abe49Wed, 05 Jul 2023 13:00:00 GMT<p>Drs. Sandeep Nathan, Alessandra Sala, and Rebecca Hahn discuss the article in JSCAI, "Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Options"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101041 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101041 </a></p> no00:21:56Tricuspid Valve Regurgitation: Current Understanding and Novel Treatment Optionsfull<![CDATA[J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device]]>Drs. David Rizik, Dean Kereiakes, Michael Reardon, and Suzanne Baron discuss the "J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device" article in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2023.101044

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/J-Valve-Transcatheter-Treatment-of-Native-Valve-Aortic-Regurgitation-Associated-With-a-Left-Ventricular-Assist-Device-e2l1qc5677e255c-5295-463d-bb93-a54c13f40103Fri, 09 Jun 2023 13:00:00 GMT<p>Drs. David Rizik, Dean Kereiakes, Michael Reardon, and Suzanne Baron discuss the "J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Device" article in JSCAI. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.101044" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101044</a></p> no00:18:45J-Valve Transcatheter Treatment of Native Valve Aortic Regurgitation Associated With a Left Ventricular Assist Devicefull<![CDATA[Update on Radiation Safety in the Cath Lab – Moving Toward a “Lead-Free” Environment]]>Drs. Andrew Goldsweig, Morton Kern, David Rizik, and William Nicholson discuss radiation safety and exposure in the cath lab.


Read the article for more information: https://doi.org/10.1016/j.jscai.2023.101040

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Update-on-Radiation-Safety-in-the-Cath-Lab--Moving-Toward-a-Lead-Free-Environment-e2l175nf1adaef7-0daa-4087-8156-30bf146de64dFri, 02 Jun 2023 13:00:00 GMT<p>Drs. Andrew Goldsweig, Morton Kern, David Rizik, and William Nicholson discuss radiation safety and exposure in the cath lab. </p> <p><br /></p> <p>Read the article for more information: <a href="https://doi.org/10.1016/j.jscai.2023.101040" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.101040</a> </p> no00:21:25Update on Radiation Safety in the Cath Lab – Moving Toward a “Lead-Free” Environmentfull<![CDATA[SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosis]]>Drs. Sandeep Nathan, Ron Waksman, Lloyd Klein, and Ziad Ali discuss the "SCAI Expert Consensus Statement on ISR and Stent Thrombosis."


Read the article: https://doi.org/10.1016/j.jscai.2023.100971

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-Management-of-In-Stent-Restenosis-and-Stent-Thrombosis-e2l171f5e98848c-1702-4633-90ee-cfc2d5ca0b63Thu, 18 May 2023 13:00:00 GMT<p>Drs. Sandeep Nathan, Ron Waksman, Lloyd Klein, and Ziad Ali discuss the "SCAI Expert Consensus Statement on ISR and Stent Thrombosis."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.100971" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.100971</a> </p> no00:17:21SCAI Expert Consensus Statement on Management of In-Stent Restenosis and Stent Thrombosisfull<![CDATA[Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directions]]>Dr. Srihari Naidu, Dr. Jentzer highlight key findings from the JSCAI article: "Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directions." Dr. Gregg Stone and Dr. Bobby Yeh participate as panelists.


Read the article: https://doi.org/10.1016/j.jscai.2023.100586

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Mechanical-Circulatory-Support-Devices-in-Acute-Myocardial-Infarction-Cardiogenic-Shock-Current-Studies-and-Future-Directions-e2l164n4b009b8e-8afc-410b-bb04-3e0c1d8e96b8Fri, 14 Apr 2023 13:00:00 GMT<p>Dr. Srihari Naidu, Dr. Jentzer highlight key findings from the JSCAI article: "Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directions." Dr. Gregg Stone and Dr. Bobby Yeh participate as panelists. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.100586" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.100586</a></p> no00:24:48Mechanical Circulatory Support Devices in Acute Myocardial Infarction-Cardiogenic Shock: Current Studies and Future Directionsfull<![CDATA[Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications]]>Drs. Dean Kereiakes, Bruno Scheller, Antonio Colombo, and Aloke Finn discuss the paper in JSCAI titled, "Coronary Drug-Coated Balloons for de novo and In-Stent Restenosis Indications."


Read the article: https://doi.org/10.1016/j.jscai.2023.100625

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Coronary-Drug-Coated-Balloons-for-De-Novo-and-In-Stent-Restenosis-Indications-e2l17dcf79ec305-4576-4497-8561-6e9a553e75deWed, 29 Mar 2023 13:00:00 GMT<p>Drs. Dean Kereiakes, Bruno Scheller, Antonio Colombo, and Aloke Finn discuss the paper in JSCAI titled, "Coronary Drug-Coated Balloons for de novo and In-Stent Restenosis Indications." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2023.100625" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2023.100625</a></p> no00:39:47Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indicationsfull<![CDATA[SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure]]>Drs. Andrew Goldsweig, Jackie Saw, Matt Price, & Dr. Faisal Merchant discuss the JSCAI article: "SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure (LAAC)."


Read the article: https://doi.org/10.1016/j.jscai.2022.100577

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAIHRS-Expert-Consensus-Statement-on-Transcatheter-Left-Atrial-Appendage-Closure-e2l16r20005965c-0457-49a5-a2cb-7cfc6eccd0aaMon, 27 Mar 2023 13:00:00 GMT<p>Drs. Andrew Goldsweig, Jackie Saw, Matt Price, &amp; Dr. Faisal Merchant discuss the JSCAI article: "SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure (LAAC)." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100577" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100577</a></p> no00:26:14SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closurefull<![CDATA[SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup]]>Drs. Jeff Carr, Ted Schrieber, Greg Dehmer, Mamas Mamas, and Cindy Grines discuss key findings from the article: "SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup," published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100560

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-Percutaneous-Coronary-Intervention-Without-On-Site-Surgical-Backup-e2l10t4828cf770-f207-486b-9644-1e3be16711b2Mon, 30 Jan 2023 14:00:00 GMT<p>Drs. Jeff Carr, Ted Schrieber, Greg Dehmer, Mamas Mamas, and Cindy Grines discuss key findings from the article: "SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup," published in JSCAI. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100560" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100560</a></p> no00:33:17SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backupfull<![CDATA[Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality]]>Drs. Edward Hannan, Alice Jacobs, John Hirshfeld, and Suzanne Baron discuss the paper in JSCAI titled, "Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality"


Read the article: https://doi.org/10.1016/j.jscai.2022.100559

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Short-term-Deaths-After-Percutaneous-Coronary-Intervention-Discharge-Prevalence--Risk-Factors--and-Hospital-Risk-Adjusted-Mortality-e2l10ou231fbc70-c940-4fd0-8d95-5275c2afc665Tue, 03 Jan 2023 14:00:00 GMT<p>Drs. Edward Hannan, Alice Jacobs, John Hirshfeld, and Suzanne Baron discuss the paper in JSCAI titled, "Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortality"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100559" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100559</a></p> no00:24:14Short-term Deaths After Percutaneous Coronary Intervention Discharge: Prevalence, Risk Factors, and Hospital Risk-Adjusted Mortalityfull<![CDATA[One-Year Results of the Portico Transcatheter Aortic Heart Valve Using the Next-Generation FlexNav Delivery System]]>Drs. Gregory Fontana, John Forrest, and Andrew Goldsweig discuss the article "One-Year Results of the Portico Transcatheter Aortic Heart Valve Using the Next-Generation FlexNav Delivery System" in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100562

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/One-Year-Results-of-the-Portico-Transcatheter-Aortic-Heart-Valve-Using-the-Next-Generation-FlexNav-Delivery-System-e2l1558fca97747-5e76-4da4-9649-88f2f1ae8930Thu, 22 Dec 2022 14:00:00 GMT<p>Drs. Gregory Fontana, John Forrest, and Andrew Goldsweig discuss the article "One-Year Results of the Portico Transcatheter Aortic Heart Valve Using the Next-Generation FlexNav Delivery System" in JSCAI.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100562" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100562</a></p> no00:22:03One-Year Results of the Portico Transcatheter Aortic Heart Valve Using the Next-Generation FlexNav Delivery Systemfull<![CDATA[Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis]]>Drs. Anthony Mathur, Daniel Burkhoff, Tim Henry, and Cindy Grines discuss critical highlights from the article in JSCAI titled: "Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis."


Read the article: https://doi.org/10.1016/j.jscai.2022.100527

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Proangiogenic-Growth-Factor-Therapy-for-the-Treatment-of-Refractory-Angina-A-Meta-analysis-e2l10qidf76e44d-f165-4b7d-a637-f9d55d9ba85eTue, 20 Dec 2022 14:00:00 GMT<p>Drs. Anthony Mathur, Daniel Burkhoff, Tim Henry, and Cindy Grines discuss critical highlights from the article in JSCAI titled: "Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysis."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100527" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100527</a></p> no00:21:15Proangiogenic Growth Factor Therapy for the Treatment of Refractory Angina: A Meta-analysisfull<![CDATA[Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysis]]>Drs. Kritvikrom Durongpisitkul, John Cheatham, Gary Raff, and Frank Ing discuss the paper in JSCAI titled, "Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysis."


Read the article: https://doi.org/10.1016/j.jscai.2022.100408

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Outcomes-of-Transcatheter-Pulmonary-Valve-Replacement-and-Surgical-Pulmonary-Valve-Replacement-A-Cohort-Analysis-e2l10h707c29275-1fe8-4a8f-97b5-7b94da7dc253Tue, 13 Dec 2022 14:00:00 GMT<p>Drs. Kritvikrom Durongpisitkul, John Cheatham, Gary Raff, and Frank Ing discuss the paper in JSCAI titled, "Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysis."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100408 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100408 </a></p> no00:40:50Outcomes of Transcatheter Pulmonary Valve Replacement and Surgical Pulmonary Valve Replacement: A Cohort Analysisfull<![CDATA[Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and SCAI]]>Drs. Anand Prasad, Charles Davidson, Steven Weisbord, and Andrew Goldsweig discuss the article in JSCAI: "Management of Patients with Kidney Disease in need of Cardiovascular Catheterization: A Scientific Workshop Co-Sponsored by the National Kidney Foundation and the Society of Cardiovascular Angiography and Interventions"


Read the document: https://doi.org/10.1016/j.jscai.2022.100445

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Management-of-Patients-With-Kidney-Disease-in-Need-of-Cardiovascular-Catheterization-A-Scientific-Workshop-Cosponsored-by-the-National-Kidney-Foundation-and-SCAI-e2l0cubb0c99681-7b18-4d4d-ad24-9a8f234cca78Thu, 01 Dec 2022 14:00:00 GMT<p>Drs. Anand Prasad, Charles Davidson, Steven Weisbord, and Andrew Goldsweig discuss the article in JSCAI: "Management of Patients with Kidney Disease in need of Cardiovascular Catheterization: A Scientific Workshop Co-Sponsored by the National Kidney Foundation and the Society of Cardiovascular Angiography and Interventions"</p> <p><br /></p> <p>Read the document:<a href=" https://doi.org/10.1016/j.jscai.2022.100445 " rel="noopener noreferrer nofollow" target="_blank"> https://doi.org/10.1016/j.jscai.2022.100445 </a></p> no00:22:28Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and SCAIfull<![CDATA[Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches]]>Drs. Ellen Roche, Renu Virmani, Dee Dee Wang, and Andrew Goldsweig for a discussion on the accepted paper in JSCAI titled, "Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches."


Read the article: https://doi.org/10.1016/j.jscai.2022.100405

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Left-Atrial-Appendage-Occlusion-Current-Stroke-Prevention-Strategies-and-a-Shift-Toward-Data-Driven--Patient-Specific-Approaches-e2l0co527fef5eb-d6af-4b29-b5f8-7c8b71212f97Mon, 28 Nov 2022 14:00:00 GMT<p>Drs. Ellen Roche, Renu Virmani, Dee Dee Wang, and Andrew Goldsweig for a discussion on the accepted paper in JSCAI titled, "Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100405 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100405 </a></p> no00:27:39Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approachesfull<![CDATA[Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review]]>Drs. Robert Attaran, Sanjay Misra, Ehrin Murphy, and Sahil Parikh discuss the paper in JSCAI titled, "Chronic Venous Disease of the Lower Extremities: A State-of-the-Art Review."


Read the article: https://doi.org/10.1016/j.jscai.2022.100538

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Chronic-Venous-Disease-of-the-Lower-Extremities-A-State-of-the-Art-Review-e2l10ld1001555c-562f-44d8-9aa3-2fc8346a1b36Sat, 26 Nov 2022 14:00:00 GMT<p>Drs. Robert Attaran, Sanjay Misra, Ehrin Murphy, and Sahil Parikh discuss the paper in JSCAI titled, "Chronic Venous Disease of the Lower Extremities: A State-of-the-Art Review."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100538" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100538</a></p> no00:20:15Chronic Venous Disease of the Lower Extremities: A State-of-the Art Reviewfull<![CDATA[Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled Trials]]>Drs. Yousif Ahmad, Philippe Genereux, and Andrew Goldsweig discuss the paper in JSCAI titled, "Early Surgical for Patients with Asymptomatic Severe Aortic Stenosis: a Meta-Analysis of Randomized Controlled Trials."


Read the article: https://doi.org/10.1016/j.jscai.2022.100383

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Early-Surgery-for-Patients-With-Asymptomatic-Severe-Aortic-Stenosis-A-Meta-Analysis-of-Randomized-Controlled-Trials-e2l0clp4f1cdf9c-4a8d-4b1f-b7cd-f9e9236df0f6Tue, 25 Oct 2022 13:00:00 GMT<p>Drs. Yousif Ahmad, Philippe Genereux, and Andrew Goldsweig discuss the paper in JSCAI titled, "Early Surgical for Patients with Asymptomatic Severe Aortic Stenosis: a Meta-Analysis of Randomized Controlled Trials." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100383" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100383</a> </p> no00:20:47Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled Trialsfull<![CDATA[Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction]]> Drs. Yousif Ahmad, Ingrid Hsiung, Samir Kapadia, and Sandeep Nathan discuss the article in JSCAI titled, "Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction."


Read the article: https://doi.org/10.1016/j.jscai.2022.100347

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Transcatheter-Aortic-Valve-Replacement-in-Patients-at-High-Risk-of-Coronary-Obstruction-e2l0cfo37e425fc-67c7-43e2-a739-cadd1a5b88b1Thu, 13 Oct 2022 13:00:00 GMT<p> Drs. Yousif Ahmad, Ingrid Hsiung, Samir Kapadia, and Sandeep Nathan discuss the article in JSCAI titled, "Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstruction." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100347 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100347 </a> </p> no00:29:28Transcatheter Aortic Valve Replacement in Patients at High Risk of Coronary Obstructionfull<![CDATA[Quantitative Flow Ratio Based on Murray Fractal Law: Accuracy of Single Versus Two Angiographic Views]]>Drs. Dean Kereiakes, Shengxian Tu, Bo Xu, and William Wijns discuss the article in JSCAI titled "Quantitative Flow Ratio Based on Murray Fractal Law: Accuracy of Single Versus Two Angiographic Views."


Read the article: https://doi.org/10.1016/j.jscai.2022.100399

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Quantitative-Flow-Ratio-Based-on-Murray-Fractal-Law-Accuracy-of-Single-Versus-Two-Angiographic-Views-e2l0cbuf03d8443-ff01-46d0-9c77-12e72728781fThu, 22 Sep 2022 13:00:00 GMT<p>Drs. Dean Kereiakes, Shengxian Tu, Bo Xu, and William Wijns discuss the article in JSCAI titled "Quantitative Flow Ratio Based on Murray Fractal Law: Accuracy of Single Versus Two Angiographic Views."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100399 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100399 </a> </p> no00:29:11Quantitative Flow Ratio Based on Murray Fractal Law: Accuracy of Single Versus Two Angiographic Viewsfull<![CDATA[First-in-Human Experience With the ModulHeart Device for Mechanical Circulatory Support and Renal Perfusion]]> Drs. Philippe Genereux, David Rizik, Navin Kapur, and Andrew Goldsweig discuss the paper in JSCAI titled, "First-in-Human Experience With the ModulHeart Device for Mechanical Circulatory Support and Renal Perfusion."


Read the article: https://doi.org/10.1016/j.jscai.2022.100449

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/First-in-Human-Experience-With-the-ModulHeart-Device-for-Mechanical-Circulatory-Support-and-Renal-Perfusion-e2l0cpp9ad190b9-eab3-4e17-bc26-fd377cd7195bSat, 17 Sep 2022 13:00:00 GMT<p> Drs. Philippe Genereux, David Rizik, Navin Kapur, and Andrew Goldsweig discuss the paper in JSCAI titled, "First-in-Human Experience With the ModulHeart Device for Mechanical Circulatory Support and Renal Perfusion."</p> <p><br /></p> <p>Read the article: https://doi.org/10.1016/j.jscai.2022.100449 </p> no00:33:41First-in-Human Experience With the ModulHeart Device for Mechanical Circulatory Support and Renal Perfusionfull<![CDATA[Ejection Fraction Improvement Following Contemporary High-Risk Percutaneous Coronary Intervention: RESTORE EF Study Results]]>Drs. Dean Kereiakes, Farouc Jaffer, and Mitul Patel discuss the JSCAI article titled, "Ejection Fraction Improvement Following Contemporary High-Risk PCI: RESTORE EF Study Results"

Read the article: https://doi.org/10.1016/j.jscai.2022.100350

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Ejection-Fraction-Improvement-Following-Contemporary-High-Risk-Percutaneous-Coronary-Intervention-RESTORE-EF-Study-Results-e2ks7sb57185301-5432-4cd5-9288-ab8befe649e9Fri, 12 Aug 2022 13:00:00 GMT<p>Drs. Dean Kereiakes, Farouc Jaffer, and Mitul Patel discuss the JSCAI article titled, "Ejection Fraction Improvement Following Contemporary High-Risk PCI: RESTORE EF Study Results" </p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100350 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100350 </a></p> no00:21:18Ejection Fraction Improvement Following Contemporary High-Risk Percutaneous Coronary Intervention: RESTORE EF Study Resultsfull<![CDATA[Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension]]>Drs. Sahil Parikh, Vikas Aggarwal, Ehtisham Mahmud, and Kenneth Rosenfield discuss the paper in JSCAI titled, "Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension."


Read the article: https://doi.org/10.1016/j.jscai.2022.100429

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Interventional-Imaging-Roadmap-to-Successful-Balloon-Pulmonary-Angioplasty-for-Chronic-Thromboembolic-Pulmonary-Hypertension-e2l0c2m60880a6f-bf5c-47e6-86e6-37654ea5971cThu, 11 Aug 2022 13:00:00 GMT<p>Drs. Sahil Parikh, Vikas Aggarwal, Ehtisham Mahmud, and Kenneth Rosenfield discuss the paper in JSCAI titled, "Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100429 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100429 </a> </p> no00:25:22Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertensionfull<![CDATA[Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literature]]> Drs. Hector Garcia-Garcia, Adnan Kastrati, Dean Kereiakes, and Jorge Sanz Sánchez, discuss the paper in JSCAI titled, "Small Vessel Coronary Artery Disease: Rationale for Standardized Definition And Critical Appraisal of the Literature."


Read the article: https://doi.org/10.1016/j.jscai.2022.100403

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Small-Vessel-Coronary-Artery-Disease-Rationale-for-Standardized-Definition-and-Critical-Appraisal-of-the-Literature-e2l0c96a32ccf7b-45be-4d3a-acf2-5a35df92d2f2Fri, 22 Jul 2022 13:00:00 GMT<p> Drs. Hector Garcia-Garcia, Adnan Kastrati, Dean Kereiakes, and Jorge Sanz Sánchez, discuss the paper in JSCAI titled, "Small Vessel Coronary Artery Disease: Rationale for Standardized Definition And Critical Appraisal of the Literature." </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100403 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100403 </a> </p> no00:31:01Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literaturefull<![CDATA[Health Care Disparities in Congenital Cardiology: Considerations Through the Lens of an Interventional Cardiologist]]>Drs. Frank Ing, Holly Bauser-Heaton, Howaida El-Said, and Ivory Crittendon for a discussion on the accepted paper in JSCAI titled, "Health Care Disparities in Congenital Cardiology; Considerations Through the Lens of an Interventional Cardiologist"


Read the article: https://doi.org/10.1016/j.jscai.2022.100388

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Health-Care-Disparities-in-Congenital-Cardiology-Considerations-Through-the-Lens-of-an-Interventional-Cardiologist-e2ks81o28c8145c-84c5-4123-bebf-7f5b5d353834Fri, 01 Jul 2022 13:00:00 GMT<p>Drs. Frank Ing, Holly Bauser-Heaton, Howaida El-Said, and Ivory Crittendon for a discussion on the accepted paper in JSCAI titled, "Health Care Disparities in Congenital Cardiology; Considerations Through the Lens of an Interventional Cardiologist"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100388 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100388 </a></p> no00:30:18Health Care Disparities in Congenital Cardiology: Considerations Through the Lens of an Interventional Cardiologistfull<![CDATA[Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial]]>Drs. William Gray, Eric Secemsky, and Sahil Parikh discuss the JSCAI article titled, "Intravascular Lithotripsy for Peripheral Artery Calcification: The Disrupt PAD III Randomized Controlled Trial Mid-term Outcomes"


Read the article: https://doi.org/10.1016/j.jscai.2022.100341

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Intravascular-Lithotripsy-for-Peripheral-Artery-Calcification-Mid-term-Outcomes-From-the-Randomized-Disrupt-PAD-III-Trial-e2ks7hn98bbc33e-f00d-43fb-832f-38b248c5106bFri, 01 Jul 2022 13:00:00 GMT<p>Drs. William Gray, Eric Secemsky, and Sahil Parikh discuss the JSCAI article titled, "Intravascular Lithotripsy for Peripheral Artery Calcification: The Disrupt PAD III Randomized Controlled Trial Mid-term Outcomes"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100341 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100341 </a></p> no00:19:37Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trialfull<![CDATA[Conversations in Interventional Cardiology: Renal Function–Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacement]]>Drs. Sarah Gualano, Charles Davidson, and Andrew Goldsweig, discuss the JSCAI article on "Renal Function Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacement."


Read the article: https://doi.org/10.1016/j.jscai.2022.100038

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Conversations-in-Interventional-Cardiology-Renal-FunctionBased-Contrast-Threshold-Predicts-Kidney-Injury-in-Transcatheter-Aortic-Valve-Replacement-e2ks71oee84c18a-f9cb-484e-98f4-8489e3d9ba68Tue, 24 May 2022 13:00:00 GMT<p>Drs. Sarah Gualano, Charles Davidson, and Andrew Goldsweig, discuss the JSCAI article on "Renal Function Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacement."</p> <p><br /></p> <p>Read the article: https://doi.org/10.1016/j.jscai.2022.100038 </p> no00:20:51Conversations in Interventional Cardiology: Renal Function–Based Contrast Threshold Predicts Kidney Injury in Transcatheter Aortic Valve Replacementfull<![CDATA[SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training]]>Drs. Suzanne Baron, Arnold Seto, David Baran, and James McCabe discuss the SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100041

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Position-Statement-on-Best-Practices-for-Percutaneous-Axillary-Arterial-Access-and-Training-e2ks7dka0eef19c-a148-4999-b191-1a9bd27b981aThu, 19 May 2022 13:00:00 GMT<p>Drs. Suzanne Baron, Arnold Seto, David Baran, and James McCabe discuss the SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training published in JSCAI.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100041 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100041 </a></p> no00:21:54SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Trainingfull<![CDATA[Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI With COVID-19: NACMI Registry]]>Drs. Odayme Quesada, Timothy Henry, Alexandra Lansky, and Mirvat Alasnag discuss the JSCAI article titled, "Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI with COVID-19: NACMI Registry"


Read the article: https://doi.org/10.1016/j.jscai.2022.100360

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Sex-Differences-in-Clinical-Characteristics--Management-Strategies--and-Outcomes-of-STEMI-With-COVID-19-NACMI-Registry-e2ks7f8b5dfa551-22d4-4813-b8de-56ace75e8214Thu, 19 May 2022 13:00:00 GMT<p>Drs. Odayme Quesada, Timothy Henry, Alexandra Lansky, and Mirvat Alasnag discuss the JSCAI article titled, "Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI with COVID-19: NACMI Registry"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100360 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100360 </a></p> no00:19:23Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI With COVID-19: NACMI Registryfull<![CDATA[Sex-Specific Outcomes after Coronary Intravascular Lithotripsy with a Patient-level Analysis of the Disrupt CAD studies]]>Drs. J. Dawn Abbott, Suzanne Baron, Yasin Hussain, and Akiko Maehara discuss "Sex-Specific Outcomes after Coronary Intravascular Lithotripsy with a Patient-level Analysis of the Disrupt CAD studies" published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100039

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Sex-Specific-Outcomes-after-Coronary-Intravascular-Lithotripsy-with-a-Patient-level-Analysis-of-the-Disrupt-CAD-studies-e2ks6at5414294e-983f-471b-bcc5-6ec86f54ebd1Thu, 19 May 2022 13:00:00 GMT<p>Drs. J. Dawn Abbott, Suzanne Baron, Yasin Hussain, and Akiko Maehara discuss "Sex-Specific Outcomes after Coronary Intravascular Lithotripsy with a Patient-level Analysis of the Disrupt CAD studies" published in JSCAI.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100039" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100039</a></p> no00:18:55Sex-Specific Outcomes after Coronary Intravascular Lithotripsy with a Patient-level Analysis of the Disrupt CAD studiesfull<![CDATA[Evaluation of the OpSens OptoWire III and Novel TAVR Algorithm to Measure Pressure Gradient During TAVR]]>Drs. Philippe Généreux, Charanjit Rihal, Tamara Atkinson, and Andrew Goldsweig discuss the JSCAI article titled, "Evaluation of the OpSens OptoWire III and Novel TAVR Algorithm to Measure Pressure Gradient During TAVR."


Read the article: https://doi.org/10.1016/j.jscai.2022.100309

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Evaluation-of-the-OpSens-OptoWire-III-and-Novel-TAVR-Algorithm-to-Measure-Pressure-Gradient-During-TAVR-e2ks78ta546aba3-25fa-4b4b-b113-30a586b00f81Tue, 17 May 2022 13:00:00 GMT<p>Drs. Philippe Généreux, Charanjit Rihal, Tamara Atkinson, and Andrew Goldsweig discuss the JSCAI article titled, "Evaluation of the OpSens OptoWire III and Novel TAVR Algorithm to Measure Pressure Gradient During TAVR."</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100309 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100309 </a></p> no00:19:13Evaluation of the OpSens OptoWire III and Novel TAVR Algorithm to Measure Pressure Gradient During TAVRfull<![CDATA[Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus]]>Drs. Dean Kereiakes, Alexander Thomas, Dawn Abbott, and Michael Farkouh discuss the JSCAI article titled, "Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus"


Read the article: https://doi.org/10.1016/j.jscai.2022.100033

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Safety-and-Efficacy-of-the-Supreme-Biodegradable-Polymer-Sirolimus-Eluting-Stent-in-Patients-With-Diabetes-Mellitus-e2ks76n1d65cf64-8930-414f-9437-372a42d57f19Tue, 17 May 2022 13:00:00 GMT<p>Drs. Dean Kereiakes, Alexander Thomas, Dawn Abbott, and Michael Farkouh discuss the JSCAI article titled, "Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100033 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100033 </a></p> no00:22:29Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitusfull<![CDATA[SCAI Guidelines for the Management of Patent Foramen Ovale]]>Drs. Cliff Kavinsky, Robert Sommer, and Andrew Goldsweig discuss the "SCAI Guidelines for the Management of Patent Foramen Ovale" published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100039

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Guidelines-for-the-Management-of-Patent-Foramen-Ovale-e2ks6rgb79733d2-7fc0-4b0b-8200-e8fb11f60889Fri, 13 May 2022 13:00:00 GMT<p>Drs. Cliff Kavinsky, Robert Sommer, and Andrew Goldsweig discuss the "SCAI Guidelines for the Management of Patent Foramen Ovale" published in JSCAI. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100039 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100039 </a></p> no00:35:06SCAI Guidelines for the Management of Patent Foramen Ovalefull<![CDATA[Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement Patients]]>Drs. Dean Kereiakes, Michael Foley, Rahul Sharma, and Molly Szerlip discuss the article in JSCAI titled, "Aortic Valve Calcium Score is Associated with Acute Stroke in TAVI Patients"


Read the article: https://doi.org/10.1016/j.jscai.2022.100349

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Aortic-Valve-Calcium-Score-Is-Associated-With-Acute-Stroke-in-Transcatheter-Aortic-Valve-Replacement-Patients-e2ks7ud9f84b2f5-6e4b-429f-bad3-7b52557faeacWed, 11 May 2022 13:00:00 GMT<p>Drs. Dean Kereiakes, Michael Foley, Rahul Sharma, and Molly Szerlip discuss the article in JSCAI titled, "Aortic Valve Calcium Score is Associated with Acute Stroke in TAVI Patients"</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100349 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100349 </a></p> no00:21:46Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement Patientsfull<![CDATA[Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis]]>Drs. Khalid Changal, Rajesh Gupta, Sasanka Jayasuriya, Jun Li, and Sahil Parikh discuss "Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis" published in JSCAI.


Read the article: https://doi.org/10.1016/j.jscai.2022.100024

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Drug-Eluting-Stents-Versus-Conventional-Endovascular-Therapies-in-Symptomatic-Infrapopliteal-Peripheral-Artery-Disease-A-Meta-analysis-e2ks6oh5556d87d-2917-4377-aaec-a15ed75feae4Mon, 09 May 2022 13:00:00 GMT<p>Drs. Khalid Changal, Rajesh Gupta, Sasanka Jayasuriya, Jun Li, and Sahil Parikh discuss "Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis" published in JSCAI.</p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100024 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100024 </a></p> no00:18:37Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysisfull<![CDATA[Conversations in Interventional Cardiology: SCAI Position Statement: CLTI Competencies for Endovascular Specialists]]>Drs. Beau Hawkins, Sahil Parikh, Jun Li, Amy Reed, and Herbert Aronow discuss the "SCAI/ACR/APMA/SCVS/SIR/SVM/SVS/VESS Position Statement on Competencies for Endovascular Specialists Providing CLTI Care" published in JSCAI. Read the article: https://doi.org/10.1016/j.jscai.2021.100015

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Conversations-in-Interventional-Cardiology-SCAI-Position-Statement-CLTI-Competencies-for-Endovascular-Specialists-e2ks6g8d7320045-7195-4b47-b6e9-792736233f9cMon, 25 Apr 2022 13:00:00 GMT<p>Drs. Beau Hawkins, Sahil Parikh, Jun Li, Amy Reed, and Herbert Aronow discuss the "SCAI/ACR/APMA/SCVS/SIR/SVM/SVS/VESS Position Statement on Competencies for Endovascular Specialists Providing CLTI Care" published in JSCAI. Read the article: https://doi.org/10.1016/j.jscai.2021.100015 </p> no00:30:05Conversations in Interventional Cardiology: SCAI Position Statement: CLTI Competencies for Endovascular Specialistsfull<![CDATA[PCI in Patients with Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes]]>Drs. Dean Keriakes, Yousif Ahmad, and Mark Petrie discuss "PCI in Heart Failure: Current Evidence, Impact of Complete Revascularization, and Techniques to Improve Outcomes" published in JSCAI.

Read the article: https://doi.org/10.1016/j.jscai.2022.100020

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/PCI-in-Patients-with-Heart-Failure-Current-Evidence--Impact-of-Complete-Revascularization--and-Contemporary-Techniques-to-Improve-Outcomes-e2ks6cn930477f5-0533-4d7a-a27a-6753860cadb2Wed, 16 Mar 2022 13:00:00 GMT<p>Drs. Dean Keriakes, Yousif Ahmad, and Mark Petrie discuss "PCI in Heart Failure: Current Evidence, Impact of Complete Revascularization, and Techniques to Improve Outcomes" published in JSCAI. </p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2022.100020 " rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2022.100020 </a></p> no00:24:57PCI in Patients with Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomesfull<![CDATA[Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Study]]>Drs. Dean Kereiakes, Margaret McEntegart, Antonio Colombo, and Andrew Goldsweig discuss the JSCAI paper "IVL treatment of severely calcified coronary lesions and the first-year study results from Disrupt CAD III" Read the full paper here: https://doi.org/10.1016/j.jscai.2021.100001

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Intravascular-Lithotripsy-for-Treatment-of-Severely-Calcified-Coronary-Lesions-1-Year-Results-From-the-Disrupt-CAD-III-Study-e2ks5l989a4b7ad-e362-4ead-ae89-166c7f142614Thu, 03 Feb 2022 14:00:00 GMT<p>Drs. Dean Kereiakes, Margaret McEntegart, Antonio Colombo, and Andrew Goldsweig discuss the JSCAI paper "IVL treatment of severely calcified coronary lesions and the first-year study results from Disrupt CAD III" Read the full paper here: <a href="https://doi.org/10.1016/j.jscai.2021.100001" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2021.100001</a> </p> no00:38:11Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Studyfull<![CDATA[SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization]]>Drs. Alexandra Lansky, J. Dawn Abbott, Suzanne Baron, Jennifer Tremmel, and Roxana Mehran for a discussion on the SCAI Expert Consensus Statement on sex-specific considerations in myocardial revascularization. Read the article: https://doi.org/10.1016/j.jscai.2021.100016

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-Expert-Consensus-Statement-on-Sex-Specific-Considerations-in-Myocardial-Revascularization-e2ks5tq0d72b933-4185-4441-a0e5-0c600652c447Wed, 02 Feb 2022 14:00:00 GMT<p>Drs. Alexandra Lansky, J. Dawn Abbott, Suzanne Baron, Jennifer Tremmel, and Roxana Mehran for a discussion on the SCAI Expert Consensus Statement on sex-specific considerations in myocardial revascularization. Read the article: <a href="https://doi.org/10.1016/j.jscai.2021.100016" rel="noopener noreferrer nofollow">https://doi.org/10.1016/j.jscai.2021.100016</a> </p> no00:35:05SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularizationfull<![CDATA[MCS in MI Complicated by Cardiogenic Shock: Impact of Sex & Timing]]>Drs. Tayyab Shah, Cindy Grines, Sandeep Nathan, and Alexandra Lansky, discuss the JSCAI article titled, "Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock: Impact of Sex and Timing".

Read the article:

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/MCS-in-MI-Complicated-by-Cardiogenic-Shock-Impact-of-Sex--Timing-e2ks63g7ba49428-48e5-4ac0-9c72-edb85d3b78bcMon, 31 Jan 2022 14:00:00 GMT<p>Drs. Tayyab Shah, Cindy Grines, Sandeep Nathan, and Alexandra Lansky, discuss the JSCAI article titled, "Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock: Impact of Sex and Timing". </p> <p>Read the article: </p> no00:17:14MCS in MI Complicated by Cardiogenic Shock: Impact of Sex & Timingfull<![CDATA[Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy]]>Drs. Kush Patel, Andreas Baumbach, Dean Kereiakes, and Martin Leon discuss the JSCAI published paper on "Outcomes of the Novel Supreme Drug-Eluting Stents in Complex Coronary Lesions: A PIONEER III Substudy" Read the full paper here: https://doi.org/10.1016/j.jscai.2021.100004

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/Outcomes-of-the-Novel-Supreme-Drug-Eluting-Stent-in-Complex-Coronary-Lesions-A-PIONEER-III-Substudy-e2ks5gl973f4e1f-96f2-4061-9801-25b42c6eaf9eMon, 31 Jan 2022 14:00:00 GMT<p>Drs. Kush Patel, Andreas Baumbach, Dean Kereiakes, and Martin Leon discuss the JSCAI published paper on "Outcomes of the Novel Supreme Drug-Eluting Stents in Complex Coronary Lesions: A PIONEER III Substudy" Read the full paper here: <a href="https://doi.org/10.1016/j.jscai.2021.100004" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2021.100004</a> </p> no00:21:04Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudyfull<![CDATA[SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies]]>Join Drs. Srihari Naidu, Tim Henry, Holger Thiele, Navin Kapur, and Sandeep Nathan for a discussion on the updated SCAI SHOCK Stage Classification Clinical Expert Consensus Update.


Read the article: https://doi.org/10.1016/j.jscai.2021.100008

]]>https://podcasters.spotify.com/pod/show/jscai/episodes/SCAI-SHOCK-Stage-Classification-Expert-Consensus-Update-A-Review-and-Incorporation-of-Validation-Studies-e2kjdc247f459e7-9d05-435b-92ee-d4c7273e52d6Mon, 31 Jan 2022 14:00:00 GMT<p>Join Drs. Srihari Naidu, Tim Henry, Holger Thiele, Navin Kapur, and Sandeep Nathan for a discussion on the updated SCAI SHOCK Stage Classification Clinical Expert Consensus Update. </p> <p><br /></p> <p>Read the article: <a href="https://doi.org/10.1016/j.jscai.2021.100008" rel="noopener noreferrer nofollow" target="_blank">https://doi.org/10.1016/j.jscai.2021.100008</a></p> no00:29:55SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studiesfull